Yoshifumi Naka

Q: What Schools Are Affiliated With Yoshifumi Naka

Yoshifumi Naka is affiliated with the following schools: University of Florida, Columbia University, Duke University

Yoshifumi Naka's AcademicInfluence.com Rankings

Yoshifumi Naka

Engineering

#4548

World Rank

#5746

Historical Rank

Biomedical Engineering

#290

World Rank

#297

Historical Rank

Mechanical Engineering

#380

World Rank

#422

Historical Rank

engineering Degrees

Download Badge

Engineering

Yoshifumi Naka's Degrees

PhD Biomedical Engineering University of Tokyo
Masters Mechanical Engineering Kyoto University
Bachelors Mechanical Engineering Kyoto University

Why Is Yoshifumi Naka Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Yoshifumi Naka's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Use of a continuous-flow device in patients awaiting heart transplantation. (2007) (1631)
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. (2009) (837)
Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection (2007) (760)
A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report (2019) (582)
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure (2017) (564)
Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. (1996) (538)
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. (2010) (535)
Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure (2018) (516)
Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond (2003) (478)
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). (2011) (451)
Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. (2006) (436)
Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis (2001) (405)
Central role of RAGE-dependent neointimal expansion in arterial restenosis. (2003) (370)
Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial (2015) (331)
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. (2012) (311)
Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. (2002) (303)
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. (1996) (287)
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. (2011) (253)
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). (2014) (236)
Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure (2012) (226)
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. (2007) (218)
Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. (2010) (218)
Prospective, Multicenter Study of Ventricular Assist Device Infections (2013) (217)
Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. (1997) (210)
Infection in permanent circulatory support: experience from the REMATCH trial. (2004) (197)
Effects of left ventricular assist device therapy on ventricular arrhythmias. (2005) (190)
Factors Associated With Primary Graft Failure After Heart Transplantation (2010) (189)
The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. (1994) (186)
Revised screening scale to predict survival after insertion of a left ventricular assist device. (2003) (182)
Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. (2013) (176)
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. (2003) (174)
The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. (2013) (171)
Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. (2004) (170)
The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. (2015) (166)
Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. (2014) (162)
Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Experience (2004) (161)
Coronary Artery Bypass Grafting in Patients With Low Ejection Fraction (2005) (159)
Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device Recipients (2014) (158)
Impella LP 2.5 for Left Ventricular Unloading During Venoarterial Extracorporeal Membrane Oxygenation Support (2011) (157)
Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? (2013) (157)
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019. (2020) (155)
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. (2012) (151)
Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. (2014) (147)
Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. (2012) (145)
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. (2010) (140)
Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. (2014) (138)
Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling (2011) (137)
Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices (2014) (137)
RAGE Axis: Animal Models and Novel Insights Into the Vascular Complications of Diabetes (2004) (136)
Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. (1994) (135)
Immunologic sensitization in recipients of left ventricular assist devices. (2003) (134)
Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. (2011) (132)
Myostatin activation in patients with advanced heart failure and after mechanical unloading (2010) (121)
Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. (2012) (120)
Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. (2004) (119)
Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. (2010) (118)
Incidence and Implications of Left Ventricular Distention During Venoarterial Extracorporeal Membrane Oxygenation Support (2017) (118)
PRETRANSPLANT CACHEXIA AND MORBID OBESITY ARE PREDICTORS OF INCREASED MORTALITY AFTER HEART TRANSPLANTATION1 (2001) (113)
Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction and Prevents Heart Failure (2007) (109)
Receptor for Advanced Glycation End Products and Its Ligands: A Journey from the Complications of Diabetes to Its Pathogenesis (2005) (109)
Validity and Reliability of a Novel Slow Cuff-Deflation System for Noninvasive Blood Pressure Monitoring in Patients With Continuous-Flow Left Ventricular Assist Device (2013) (107)
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. (2005) (105)
Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. (2011) (104)
Survival After Heart Transplantation Is Not Diminished Among Recipients With Uncomplicated Diabetes Mellitus: An Analysis of the United Network of Organ Sharing Database (2006) (104)
Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. (2015) (104)
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. (2006) (104)
Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. (1995) (101)
The Effect of Body Mass Index on Survival Following Heart Transplantation: Do Outcomes Support Consensus Guidelines? (2010) (101)
Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database. (2010) (97)
HeartMate VE LVAS design enhancements and its impact on device reliability. (2004) (94)
Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison (2014) (94)
Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation (2012) (92)
Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults (2017) (91)
Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery. (2013) (90)
Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation. (2012) (88)
Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant. (2017) (85)
Bridge-to-Decision Therapy With a Continuous-Flow External Ventricular Assist Device in Refractory Cardiogenic Shock of Various Causes (2014) (84)
Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States (2017) (82)
Cardiac Transplantation Using Extended-Donor Criteria Organs for Systemic Amyloidosis Complicated by Heart Failure (2007) (82)
Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry. (2018) (81)
SdrF, a Staphylococcus epidermidis Surface Protein, Contributes to the Initiation of Ventricular Assist Device Driveline–Related Infections (2009) (78)
Nuclear Factor Interleukin 6 Motifs Mediate Tissue-specific Gene Transcription in Hypoxia* (1997) (78)
Outcomes after stroke complicating left ventricular assist device. (2016) (77)
Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. (2014) (76)
Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. (2009) (76)
A novel approach to percutaneous right-ventricular mechanical support. (2012) (76)
Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. (1997) (75)
Randomized, multicenter trial comparing sternotomy closure with rigid plate fixation to wire cerclage (2017) (75)
A decade experience of cardiac retransplantation in adult recipients. (2005) (75)
Impact of Center Volume on Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy: Analysis of the Thoratec HeartMate Registry, 1998 to 2005 (2009) (74)
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent (2020) (73)
Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation. (2019) (73)
Effect of left ventricular assist device infection on post-transplant outcomes. (2009) (73)
Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. (2006) (70)
Association of low ejection fraction with impaired verbal memory in older patients with heart failure. (2011) (70)
Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center (2015) (69)
Alternate waiting list strategies for heart transplantation maximize donor organ utilization. (2005) (68)
cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation. (1996) (68)
Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing (2009) (68)
Increased de novo ceramide synthesis and accumulation in failing myocardium. (2017) (67)
Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices (2011) (66)
Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation. (2019) (66)
Clinical indication for use and outcomes after inhaled nitric oxide therapy. (2006) (66)
Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. (2015) (64)
Mechanical support for the failing cardiac allograft: a single-center experience. (2003) (63)
Association of device surface and biomaterials with immunologic sensitization after mechanical support. (2008) (62)
The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. (2006) (61)
Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms. (2015) (61)
Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Requirement for graft vascular homeostasis beyond harvest vasodilation. (1995) (59)
Feasibility of smaller arterial cannulas in venoarterial extracorporeal membrane oxygenation. (2015) (59)
Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: a two-center study. (2005) (59)
Post–Heart Transplant Survival Is Inferior at Low-Volume Centers Across All Risk Strata (2010) (59)
Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. (1995) (58)
Matching high-risk recipients with marginal donor hearts is a clinically effective strategy. (2009) (58)
Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). (2016) (57)
Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution (2016) (57)
Diabetic vascular disease: it's all the RAGE. (2005) (57)
Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice. (2008) (56)
Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients. (2018) (56)
Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation. (1997) (56)
Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections. (2016) (55)
The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. (2016) (55)
Continuous-flow left ventricular assist device exchange: clinical outcomes. (2014) (55)
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. (2006) (54)
Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. (2013) (52)
PKCβ regulates ischemia/reperfusion injury in the lung (2004) (52)
Role of the Abiomed BVS 5000 Device for Short-Term Support and Bridge to Transplantation (2004) (52)
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association (2021) (51)
Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome. (2015) (51)
Contemporary mechanical circulatory support therapy for postcardiotomy shock (2016) (51)
Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. (2018) (50)
Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation. (2005) (50)
Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant model. (1995) (50)
Cardiac transplantation in patients with hypertrophic cardiomyopathy. (2012) (50)
Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. (1998) (50)
Effect of gender on bridging to transplantation and posttransplantation survival in patients with left ventricular assist devices. (2004) (49)
Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. (2014) (49)
Mitral Valve Repair at the Time of Continuous-Flow Left Ventricular Assist Device Implantation Confers Meaningful Decrement in Pulmonary Vascular Resistance (2013) (49)
Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation. (2013) (48)
RAGE and its ligands: a lasting memory in diabetic complications? (2004) (46)
Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants (2021) (45)
Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant. (2020) (45)
Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database. (2015) (45)
Potentiation of Endogenous Fibrinolysis and Rescue from Lung Ischemia/Reperfusion Injury in Interleukin (IL)-10-reconstituted IL-10 Null Mice* (2000) (44)
Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy. (2015) (44)
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. (2020) (43)
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure (2014) (43)
cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy. (2000) (43)
Acute Mechanical Circulatory Support for Fulminant Myocarditis Complicated by Cardiogenic Shock (2014) (43)
Human immunodeficiency virus infection and left ventricular assist devices: a case series. (2011) (43)
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. (2018) (42)
Surgical management of patients in the REMATCH trial. (2003) (42)
Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death (2016) (42)
Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. (2015) (41)
Staphylococcus epidermidis colonization is highly clonal across US cardiac centers. (2012) (41)
Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation. (2013) (41)
Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration (2017) (41)
PKCbeta regulates ischemia/reperfusion injury in the lung. (2004) (41)
Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database. (2014) (41)
Socioeconomic Disparities in Adherence and Outcomes After Heart Transplant: A UNOS (United Network for Organ Sharing) Registry Analysis (2018) (40)
Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. (2007) (40)
Heart transplant and left ventricular assist device costs. (2005) (40)
EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device (2019) (40)
The Rapid Transformation of Cardiac Surgery Practice in the Coronavirus Disease 2019 (COVID-19) Pandemic: Insights and Clinical Strategies From a Center at the Epicenter (2020) (39)
Utility of 3D Printed Cardiac Models for Medical Student Education in Congenital Heart Disease: Across a Spectrum of Disease Severity (2019) (39)
Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation. (2017) (39)
Timing of Temporary Right Ventricular Assist Device Insertion for Severe Right Heart Failure After Left Ventricular Assist Device Implantation (2013) (38)
Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry. (2017) (38)
Increased de novo ceramide synthesis and accumulation in failing myocardium. (2017) (38)
Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation--single-center retrospective analysis. (2012) (38)
Which patient, which pump? (2003) (38)
Long-term outcome of patients on continuous-flow left ventricular assist device support. (2014) (38)
Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure. (2000) (37)
Advanced heart failure in patients infected with human immunodeficiency virus: is there equal access to care? (2014) (37)
Ventricular assist device use for the treatment of acute viral myocarditis. (2006) (37)
Nutritional status in patients on left ventricular assist device support. (2005) (36)
New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes. (2011) (36)
The human thymus perivascular space is a functional niche for viral-specific plasma cells (2016) (36)
Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis (2012) (35)
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. (2018) (35)
Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices. (2014) (35)
Changes in End-Organ Function in Patients With Prolonged Continuous-Flow Left Ventricular Assist Device Support. (2017) (35)
Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant. (2019) (35)
Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report. (2003) (35)
Asymmetric Pattern of Cerebrovascular Lesions in Patients After Left Ventricular Assist Device Implantation (2012) (35)
Effect of Donor Age on Long‐Term Survival Following Cardiac Transplantation (2006) (34)
Does bridging to transplantation with a left ventricular assist device adversely affect posttransplantation survival? A comparative analysis of mechanical versus inotropic support. (2003) (34)
Catheter Ablation for Ventricular Tachyarrhythmias in Patients Supported by Continuous-Flow Left Ventricular Assist Devices (2014) (34)
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score. (2014) (34)
Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. (2015) (34)
Ventricular assist device therapy. (2009) (34)
Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices (2016) (34)
Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation. (2017) (33)
Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist DevicesCLINICAL PERSPECTIVE (2016) (33)
Preserved Gastric Tonometric Variables in Cardiac Surgical Patients Administered Intravenous Perflubron Emulsion (2002) (33)
Device Exchange in HeartMate II Recipients: Long-Term Outcomes and Risk of Thrombosis Recurrence (2015) (32)
LVAD support in patients with bioprosthetic valves. (2002) (32)
Use of the AB5000 ventricular assist device in cardiogenic shock after acute myocardial infarction. (2010) (32)
Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. (2011) (32)
In vitro characterization of aortic retrograde and antegrade flow from pulsatile and non-pulsatile ventricular assist devices. (2004) (32)
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. (2020) (31)
Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock (2016) (31)
Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes (2018) (31)
Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement. (2014) (30)
The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis. (2017) (29)
Overcoming Electromagnetic Interference by LVADs on ICD Function by Shielding the ICD Programmer Wand and Extension Cable (2009) (29)
Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge. (2016) (29)
Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure. (2016) (29)
Aortic valve procedures at the time of ventricular assist device placement. (2011) (29)
Preoperative Serum Albumin Levels Predict 1-Year Postoperative Survival of Patients Undergoing Heart Transplantation (2013) (29)
Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis. (2018) (28)
Preoperative Assessment of High-Risk Candidates to Predict Survival After Heart Transplantation (2013) (28)
The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory Support (2017) (28)
Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices. (2017) (27)
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. (2022) (27)
Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing). (2016) (27)
Atrial Fibrillation in Patients With Left Ventricular Assist Devices: Incidence, Predictors, and Clinical Outcomes. (2016) (27)
Contemporary outcome of unplanned right ventricular assist device for severe right heart failure after continuous-flow left ventricular assist device insertion. (2017) (26)
Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation (2016) (26)
Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality (2019) (26)
Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock (2018) (26)
Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support (2015) (26)
Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation (2010) (25)
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. (2018) (25)
Implantation of a left ventricular assist device and the hub-and-spoke system in treating acute cardiogenic shock: who survives? (2003) (25)
The CentriMag ventricular assist device in acute heart failure refractory to medical management. (2012) (25)
ACL reconstruction using bone‐tendon‐bone graft engineered from the semitendinosus tendon by injection of recombinant BMP‐2 in a rabbit model (2011) (24)
Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion. (2019) (24)
Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn—Columbia Risk Score (2015) (24)
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. (2020) (24)
Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: the DuraHeart trial. (2014) (24)
Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation. (2005) (23)
Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist Device (2018) (23)
Value of Serial Echo‐Guided Ramp Studies in a Patient with Suspicion of Device Thrombosis after Left Ventricular Assist Device Implantation (2014) (23)
Secondary surgical‐site infection after coronary artery bypass grafting: A multi‐institutional prospective cohort study (2017) (23)
Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation (2017) (23)
Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model. (1999) (23)
Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation. (2020) (23)
The Impella Recover LP 5.0 left ventricular assist device: a bridge to coronary artery bypass grafting and cardiac transplantation. (2006) (23)
Predictors of mortality after short-term ventricular assist device placement. (2011) (22)
Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy. (2016) (22)
An injectable composite material containing bone morphogenetic protein‐2 shortens the period of distraction osteogenesis in vivo (2011) (21)
Bridge to durable left ventricular assist device for refractory cardiogenic shock (2017) (21)
Timing of nitric oxide donor supplementation determines endothelin-1 regulation and quality of lung preservation for transplantation. (2002) (21)
Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding. (2017) (21)
Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation (2012) (20)
Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. (2015) (20)
Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure. (2012) (20)
Comparison of outcomes after heart replacement therapy in patients over 65 years old. (2015) (20)
Advanced cardiovascular life support algorithm for the management of the hospitalized unresponsive patient on continuous flow left ventricular assist device support outside the intensive care unit (2016) (20)
The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: Insights and clinical strategies from a center at the epicenter (2020) (19)
A continuous‐flow external ventricular assist device for cardiogenic shock: Evolution over 10 years (2018) (19)
Mechanical Circulatory Support Therapy In Advanced Heart Failure (2007) (19)
Importance of stratifying acute kidney injury in cardiogenic shock resuscitated with mechanical circulatory support therapy (2017) (19)
Device Related Infections While on Left Ventricular Assist Device Support Do Not Adversely Impact Bridging to Transplant or Posttransplant Survival (2003) (19)
Concomitant repair for mild aortic insufficiency and continuous-flow left ventricular assist devices (2017) (19)
Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy (2018) (18)
National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States. (2016) (18)
Usefulness of Tricuspid Annular Diameter to Predict Late Right Sided Heart Failure in Patients With Left Ventricular Assist Device. (2018) (18)
Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy. (2019) (18)
Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation. (2005) (18)
Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device. (2016) (17)
Intravenous allicin improves pulmonary blood flow after ischemia-reperfusion injury in rats. (2002) (17)
Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure. (2005) (16)
Withdrawal of Left Ventricular Assist Devices: A Retrospective Analysis from a Single Institution. (2020) (16)
Transition of a Large Tertiary Heart Failure Program in Response to the COVID-19 Pandemic (2020) (16)
Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device. (2019) (16)
The PROCEED II International Heart Transplant Trial with the Organ Care System Technology (OCS) (2013) (16)
Prevalence and timing of bend relief disconnection in patients supported by the late version HeartMate II left ventricular assist device. (2013) (16)
Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes. (2014) (16)
Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? (2003) (16)
Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device (2020) (15)
Rigid Plate Fixation Versus Wire Cerclage: Patient-Reported and Economic Outcomes From a Randomized Trial. (2018) (15)
Epicardial catheter ablation through subxiphoid surgical approach in a patient with implanted left ventricular assist device and cannula-related ventricular tachycardia. (2014) (15)
Profiling non‐HLA antibody responses in antibody‐mediated rejection following heart transplantation (2020) (15)
Concomitant mitral repair and continuous‐flow left ventricular assist devices: Is it warranted? (2017) (15)
Validation of continuous thermodilution cardiac output in patients implanted with a left ventricular assist device. (2002) (15)
Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications. (2016) (15)
Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus. (2007) (15)
The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a centre at the epicentre (2020) (15)
United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis (2020) (15)
Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy. (2014) (15)
Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation. (2019) (15)
The ligand/RAGE axis: Lighting the fuse and igniting vascular stress (2006) (14)
Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices (2016) (14)
Older recipient age is associated with reduced alloreactivity and graft rejection after cardiac transplantation. (2001) (14)
Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy. (2016) (14)
Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices. (2018) (14)
Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients. (2017) (14)
Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage. (2018) (14)
Peripheral blood mononuclear cell transcriptome profiles suggest T-cell immunosuppression after uncomplicated mechanical circulatory support device surgery. (2010) (14)
Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery. (2018) (14)
Less invasive left ventricular assist device placement for difficult resternotomy. (2010) (13)
Superior protection in orthotopic rat lung transplantation with cyclic adenosine monophosphate and nitroglycerin-containing preservation solution. (1999) (13)
Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement. (2016) (13)
Use of Ventricular Assist Devices in Patients with Mitral Valve Prostheses (2011) (12)
Selective reduction of PVR by inhalation of a cGMP analogue in a porcine model of pulmonary hypertension. (1995) (12)
Palliative Care Interventions before Left Ventricular Assist Device Implantation in Both Bridge to Transplant and Destination Therapy. (2017) (12)
Late bleeding from right internal mammary artery after HeartMate left ventricular assist device implantation. (2004) (12)
Increased Levels of Retinol Binding Protein 4 in Patients With Advanced Heart Failure Correct After Hemodynamic Improvement Through Ventricular Assist Device Placement (2012) (12)
Devices as destination therapy. (2003) (12)
Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement. (2011) (12)
The influence of advanced age on venous–arterial extracorporeal membrane oxygenation outcomes (2018) (12)
Changing Trends in Mechanical Circulatory Assistance: (2004) (12)
Amiodarone Treatment Prior to Heart Transplantation Is Associated with Acute Graft Dysfunction and Early Mortality: A Propensity-Matched Comparison (2014) (12)
Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. (2022) (12)
Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience. (2015) (11)
Longer duration of continuous-flow ventricular assist device support predicts greater hemodynamic compromise after return of pulsatility. (2008) (11)
Non-invasive measurement of peripheral, central and 24-hour blood pressure in patients with continuous-flow left ventricular assist device. (2017) (11)
Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation (2016) (11)
Do posttransplant outcomes differ in heart transplant recipients bridged with continuous and pulsatile flow left ventricular assist devices? (2011) (11)
Should heart transplant recipients with early graft failure be considered for retransplantation? (2011) (11)
Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: the short-to-shield phenomenon. (2015) (11)
Correlation Between Home INR and Core Laboratory INR in Patients Supported with Continuous-Flow Left Ventricular Assist Devices (2015) (11)
Transcranial Doppler is an effective method in assessing cerebral blood flow patterns during peripheral venoarterial extracorporeal membrane oxygenation (2019) (11)
Palliative Care Consultation in Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Retrospective Cohort Study. (2019) (10)
241 A Wireless Hemodynamic Pressure Sensor before and after Ventricular Assist Device Placement: A Sub-Study of the CHAMPION Trial (2011) (10)
Ventricular assist device-associated thrombus. (2011) (9)
Effect of Socioeconomic Status on Patients Supported with Contemporary Left Ventricular Assist Devices (2020) (9)
Novel technique to repair type A acute aortic dissection in patients with a left ventricular assist device. (2001) (9)
Bridging to transplantation with left ventricular assist devices: outcomes in patients aged 60 years and older. (2005) (9)
Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation (2020) (9)
T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy (2020) (9)
Early venoarterial extracorporeal membrane oxygenation improves outcomes in post-cardiotomy shock (2020) (8)
Does Renal Function Deteriorate More Rapidly in Diabetic Cardiac Transplant Recipients? (2007) (8)
Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19 (2020) (8)
Association between "Unacceptable Condition" Expressed in Palliative Care Consultation before Left Ventricular Assist Device Implantation and Care Received at the End of Life. (2020) (8)
Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices. (2017) (8)
Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital. (2012) (8)
Outcomes of bridge to cardiac retransplantation in the contemporary mechanical circulatory support era. (2019) (8)
Adverse Event Profile Associated with Prolonged Use of CentriMag Ventricular Assist Device for Refractory Cardiogenic Shock. (2019) (8)
Perioperative Pharmacotherapy in Patients with Left Ventricular Assist Devices (2004) (8)
Similar survival in patients following heart transplantation receiving induction therapy using daclizumab vs. basiliximab. (2015) (7)
Outflow Graft Narrowing of the Heartmate 3 Left Ventricular Assist Device: Incidence, Imaging Findings, and Outcomes (2021) (7)
Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes (2021) (7)
Discontinuing amiodarone treatment prior to heart transplantation lowers incidence of severe primary graft dysfunction (2020) (7)
Transmission of Pulsatility Into the Brain of Patients with Continuous-Flow Left Ventricular Assist Devices (2018) (7)
511: Selection of UNOS Status 1A Candidates for Mechanical Circulatory Support as Bridge-to-Transplantation (BTT) – Analysis of UNOS/OPTN 2000-2005 (2008) (7)
End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy. (2018) (7)
Tips on tuning each device: technical pearls. (2011) (7)
Surgical Treatment for Advanced Heart Failure (2013) (7)
Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry (2012) (7)
The future of left ventricular assist device therapy in adults (2006) (7)
108 Tricuspid Valve Repair during Left Ventricular Assist Device Insertion (2011) (6)
Sex differences in patients with cardiogenic shock requiring extracorporeal membrane oxygenation. (2020) (6)
Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. (2017) (6)
Device exchange from HeartMate II to HeartMate 3 left ventricular assist device. (2019) (6)
Conduction Abnormalities Associated with Tricuspid Annuloplasty in Cardiac Transplantation. (2019) (6)
Impairment of Myocardial Glutamine Homeostasis Induced By Suppression of the Amino Acid Carrier SLC1A5 in Failing Myocardium. (2019) (6)
Initial multicenter clinical results with the HeartMate® II axial flow left ventricular assist device (2005) (6)
Outcomes of heart transplantation in adult congenital heart disease with prior intracardiac repair. (2020) (6)
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump (2021) (6)
Association between recipient blood type and heart transplantation outcomes in the United States. (2020) (6)
Current Options for Mechanical Heart Technology (2001) (6)
VA‐ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted? (2018) (6)
Current Management of Left Ventricular Assist Device Erosion (2013) (6)
Subcostal to rib-cross incision for HeartMate II explantation: a case report. (2013) (6)
Impact of Bridge to Transplant with Continuous Flow Left Ventricular Assist Devices on Post-Transplant Mortality: A Propensity Matched Analysis of the UNOS Database. (2019) (6)
LVAD implantation following repair of acute postmyocardial infarction ventricular septal defect (2016) (6)
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant (2015) (6)
Does a pre-left ventricular assist device screening score predict long-term transplantation success? A 2-center analysis. (2006) (5)
Exception Status Listing in the New Adult Heart Allocation System (2021) (5)
A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre (2021) (5)
Development of a murine ventricular assist device transcutaneous drive-line model. (2008) (5)
End-stage heart failure: which options? (2002) (5)
Effects of changes in UNOS policy regarding left ventricular assist devices. (2004) (5)
Intravenous immunoglobulin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IGG positive cross matches. (2001) (5)
Abstract 2586: Tricuspid Valve Repair During Left Ventricular Assist Device Insertion (2007) (5)
Intraoperative Management Issues in Mechanical Circulatory Support (2012) (5)
Left Ventricular Assist Devices (2005) (5)
Midterm Outcomes of Bridge-to-Recovery Patients After Short-Term Mechanical Circulatory Support. (2019) (5)
Atrial Fibrillation Is Associated with Recurrent Ventricular Arrhythmias After LVAD Implant: Incidence and Impact in a Consecutive Series (2019) (5)
Late outcomes of subcostal exchange of the HeartMate II left ventricular assist device: a word of caution (2018) (5)
Increased Aortic Stiffness is Associated with Higher Rates of Stroke, GI-bleeding and Pump Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients (2018) (5)
High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation. (2019) (5)
Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis (2021) (5)
Incidence and Outcomes of Prosthetic Valve Thrombosis during Extracorporeal Membrane Oxygenation Support for Postcardiotomy Shock (2019) (5)
Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies. (2021) (5)
Bleeding and Thrombotic Events During Extracorporeal Membrane Oxygenation for Postcardiotomy Shock. (2021) (4)
Endotoxaemia during left ventricular assist device insertion: relationship between risk factors and outcome. (2004) (4)
Off-pump epicardial atrial fibrillation surgery utilizing a novel bipolar radiofrequency system. (2006) (4)
Impact of Venoarterial Extracorporeal Membrane Oxygenation Flow on Outcomes in Cardiogenic Shock (2021) (4)
Characteristics and Outcomes of LVAD patients with COVID-19 (2020) (4)
Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof‐of‐concept study (2021) (4)
A mouse aortic patch model for mechanical circulatory support. (2005) (4)
Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance and Normalizes Cardiac Metabolism in Advanced Heart Failure (2010) (4)
METHYLENE BLUE DOES NOT IMPROVE VASOPLEGIA FOLLOWING LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION. (2020) (4)
In vitro evaluation of neonatal human immunity against the pig. (1996) (4)
Chronotropic Incompetence May Impact Exercise Capacity in Patients Supported by Left Ventricular Assist Device (2013) (4)
The Columbia Experience of 163 Patients with Venoarterial Extracorporeal Membranous Oxygenation for Refractory Cardiogenic Shock (2014) (4)
Lactate Dehydrogenase Isoenzyme Monitoring in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2016) (4)
Abnormal gastric tonometric variables and vasoconstrictor use after left ventricular assist device insertion. (2003) (4)
Partial Flow with 15F Arterial Cannula Provides Sufficient Circulatory Support in Veno-Arterial Extracorporeal Membrane Oxygenation (2014) (4)
Short-Term Ventricular Assist Devices (Implantable and Percutaneous) (2014) (4)
Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device. (2021) (4)
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia. (2018) (4)
Obesity is not a contraindication to veno-arterial extracorporeal life support. (2021) (4)
249: Postoperative Heparin Is Not Required in Transitioning Patients with HeartMate II LVAD to Long Term Warfarin Therapy (2009) (4)
Aortic Root Thrombus Formation in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2016) (4)
Nontransplant surgical options for congestive heart failure. (2003) (4)
Bridging to Transplant With Fully Implantable Biventricular Assist Devices vs. Total Artificial Heart Implantation in Patients With Advanced Biventricular Failure (2015) (4)
Is Lactate Level during Warm Perfusion a Predictor for Post Transplant Outcomes (2013) (4)
A stepwise progression in the treatment of cardiogenic shock. (2012) (4)
Impact of Obesity on Readmission in Patients With Left Ventricular Assist Devices. (2018) (4)
National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support. (2021) (4)
The Prevalence of Aortic Insufficiency in Patients Maintained on Continuous Flow Left Ventricular Assist Devices (2013) (4)
Reinforcement of HeartMate II bend relief connection: champagne bottle technique. (2013) (4)
Predictors of Survival and Ventricular Recovery Following Acute Myocardial Infarction Requiring Extracorporeal Membrane Oxygenation Therapy (2022) (3)
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. (2022) (3)
Regulation of human endometrial and decidual cell functions--role of epidermal growth factor in the decidualization. (1989) (3)
Long Term Outcomes for LVAD Patients Who Underwent Speed Optimization Using Pre-Discharge Ramp Test (2013) (3)
Endoscopic Algorithm for Management of Gastrointestinal Bleeding in Patients with CF-LVADs: A Prospective Validation Study. (2019) (3)
The Relationship Between Psychological Symptoms and Ventricular Assist Device Implantation. (2017) (3)
Mechanical Circulatory Support for Right Ventricular Failure (2022) (3)
Serial assessment of HeartMate 3 pump position and inflow angle and effects on adverse events. (2021) (3)
De-Novo Human Leukocyte Antigen Allosensitization on HeartMate 3 versus HeartMate II Left Ventricular Assist Device Recipients. (2020) (3)
Late inflow or outflow obstruction requiring surgical intervention after HeartMate 3 left ventricular assist device insertion. (2020) (3)
Driveline Infection Is Not Associated With Increased Risk of Thrombotic Events in CF-LVAD Patients (2015) (3)
675 LVADs for less acutely ill patients: do current data justify the strategy? (2008) (3)
ECPELLA: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device (2016) (3)
Risk Score To Predict Survival to Hospital Discharge after Left-Ventricular Assist Device (LVAD) Implantation as Destination Therapy (DT) (2006) (3)
Effect of pulmonary hypertension on transplant outcomes in patients with ventricular assist devices. (2019) (3)
REPAIR OF A MENISCUS DEFECT THROUGH CARTILAGINOUS METAPLASIA OF THE AUTOGENOUS TENDON GRAFT BY INJECTING RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (2011) (3)
De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients (2021) (3)
518: The VentrAssist LVAD as a Bridge to Cardiac Transplantation: Results of the U.S. Feasibility Trial (2008) (3)
Cerebral vasoreactivity in HeartMate 3 patients. (2021) (3)
Pain and Functional Status in Patients With Ventricular Assist Devices. (2016) (3)
Heart Transplantation After Ex-Vivo Perfusion of the Donor Hearts: Does it Affect Inotropic Use and Hospital Stay? (2014) (3)
Routine Right Heart Catheterization in LVAD Patients Awaiting Heart Transplant: What is the Appropriate Surveillance Interval? (2019) (3)
Predictors of Prolonged Status 1A Wait Time Prior to Heart Transplant (2013) (3)
7: The Columbia Experience with the Levitronix CentriMag as a Rescue Device in High Risk Patients (2010) (3)
Post-transplant survival estimation using pre-operative albumin levels. (2014) (3)
Extended trans-septal and left atrial dome incision combined with Manouguian's aortotomy for complex double valve surgery. (2014) (3)
EFFECT OF RACE ON OUTCOMES IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES (LVADs) (2004) (3)
Orthopedic Principles to Facilitate Enhanced Recovery After Cardiac Surgery. (2020) (3)
269 Aortic Valve Repair at the Time of Continuous-Flow Left Ventricular Assist Device Implantation (2011) (2)
Cardiac transplantation in adult congenital heart disease with prior sternotomy (2021) (2)
The difference between cystatin C‐ and creatinine‐based assessment of kidney function in acute heart failure (2022) (2)
Abstract 20395: High Incidence of Elevated Panel Reactive Antibodies in Patients Supported with HeartMate II Left Ventricular Assist Devices (2010) (2)
PROPHYLACTIC ANTIBIOTIC PASTE REDUCES LEFT VENTRICULAR ASSIST DEVICE POCKET INFECTIONS (2002) (2)
Increased Aortic Stiffness Is Associated With Higher Rates of Stroke, Gastrointestinal Bleeding and Pump Thrombosis in Patients With a Continuous Flow Left Ventricular Assist Device (2021) (2)
ADVANCED HEART FAILURE (2007) (2)
Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients (2019) (2)
A simple method of creating LVAD outflow tract aortic anastomosis. (2005) (2)
Role of left atrial appendage occlusion in patients with HeartMate 3 (2021) (2)
Combined Therapy of Ventricular Assist Device and Membrane Oxygenator for Profound Acute Cardiopulmonary Failure (2017) (2)
Laterality of Cerebral Artery Hemodynamics in Continuous-Flow LVAD Patients: A Pilot Study in Relation to Stroke (2018) (2)
Myocardial Recovery From Short- and Long-Term Cardiac Support Devices: Results From the UNOS Registry (2015) (2)
Increased Aortic Stiffness is Associated with Higher Rates of Stroke, GI-bleeding and Pump Thrombosis in CF-LVAD Patients. (2021) (2)
Left Ventricular Assist Devices for Advanced Heart Failure. (2017) (2)
VAD Support of the Fontan Circulation: An Analysis of the STS Pedimacs and Intermacs Databases (2021) (2)
Ventricular assist (2014) (2)
Advanced Heart Failure Therapy in HIV Positive Patients: Do These Patients Get Equal Treatment? (2013) (2)
Development of De Novo Aortic Insufficiency in Patients with HeartMate 3. (2021) (2)
Left Ventricular Assist Device Support-Induced Alteration of Mechanical Stress on Aortic Valve and Aortic Wall (2021) (2)
State of the Art Review: Evolution and Ongoing Challenges of Left Ventricular Assist Device Therapy (2018) (2)
Implantable Cardioverter-Defibrillators in Heart Transplant Recipients with Allograft Failure (2019) (2)
72 Degree of End Organ Damage as a Predictor of Outcomes after Mechanical Circulatory Support Device Implantation – A More Quantitative Assessment (2011) (2)
Abstract 13840: Leukocyte Gene Expression Signatures of MultiOrgan Dysfunction After Mechanical Circulatory Support Device Implantation in Patients with Heart Failure (2010) (2)
58: Thyroid Deficiency Is Common in Advanced Heart Failure and Associated with Increased Operative Mortality after Assist Device Implantation (2010) (2)
Validity and Reliability of a Next Generation Non-Invasive Blood Pressure Monitor in Patients with Continuous-Flow Left Ventricular Assist Device (2016) (2)
Red Cell Distribution Width (RDW) Predicts 90-Day Mortality in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients (2016) (2)
Challenges faced in long term ventricular assist device support (2016) (2)
Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system (2021) (2)
Giant Cell Myocarditis Patients Undergoing Heart Transplantation Have High Rates of Rejection, Infection and Cardiac Allograft Vasculopathy: Case Series (2018) (2)
Favorable Outcomes in Dialysis Dependent Patients on LVAD BTT Support (2015) (2)
Role of computed tomography angiography for HeartMate II left ventricular assist device thrombosis (2018) (2)
Economic costs associated with implantable left ventricular assist device therapy (2001) (2)
Cardiac transplantation in over 2000 patients: a single-institution experience from Columbia University. (2011) (2)
Management and Outcome of Left Ventricular Distention During Venoarterial Extracorporeal Membrane Oxygenation Support (2015) (2)
Residual Tricuspid Regurgitation following Tricuspid Valve Repair during Concomitant Valve Surgery Worsens Late Survival. (2015) (2)
Upfront RVAD Strategy and Early Clinical Outcomes in LVAD Patients. (2020) (2)
208: Cardiac Transplant Anastomosis and the Need for Permanent Pacemaker Implantation: An Analysis of the United Network for Organ Sharing Database (2008) (2)
CHANGING COST-EFFECTIVENESS OF LEFT VENTRICULAR ASSIST DEVICES AS DESTINATION THERAPY (2010) (2)
PRESENCE OF INTRACARDIAC THROMBUS AT THE TIME OF LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IS ASSOCIATED WITH INCREASED RISK OF STROKE AND DEATH. (2021) (2)
Impact of Sharing O Heart With Non-O Recipients: Simulation in the United Network for Organ Sharing Registry. (2018) (2)
Impact of Induction Immunosuppression on Post-Transplant Outcomes of Patients Bridged with Contemporary Left Ventricular Assist Devices (2020) (2)
Primary Graft Failure Following Cardiac Transplantation Is Associated with Elevated Pre-Transplant Levels of Pro-Inflammatory Factors (2016) (2)
Destination therapy: an alternative for end-stage heart failure patients not eligible for heart transplantation (2005) (2)
234: Effect of clenbuterol on cardiac and skeletal muscle function during LVAD support (2006) (2)
Proposal for Advanced Life Support Algorithm in Unresponsive Hospitalized LVAD Patients (2013) (2)
Twenty-four-hour blood pressure and heart rate variability are reduced in patients on left ventricular assist device support. (2022) (2)
Clinical and Hemodynamic Efficacy of Left Ventricular Unloading during Venoarterial Extracorporeal Membrane Oxygenation (2021) (1)
686: Validation of Destination Therapy Risk Score in Recipients of Left-Ventricular Assist Devices (LVAD) at a Single Center (2009) (1)
A minimally invasive right ventricular assist device insertion late after a continuous-flow left ventricular assist device implantation. (2018) (1)
Association of Warfarin Genotype With Thrombosis and Bleeding Events in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients (2015) (1)
262: Primary Graft Failure Following Heart Transplantation: Risk Factors and Outcomes (2009) (1)
502: Geographic Changes in Waitlist Survival after Initiation of New Heart Allocation Policy (2010) (1)
Assessment of Wall Shear Stress on the Aortic Valve in Patients with Left Ventricular Assist Device Using Vector Flow Mapping (2019) (1)
Hemocompatibility of a Fully Magnetically Levitated Centrifugal LVAD: Results from the DuraHeart Pivotal Trial (2013) (1)
216 Effect of LVAD on the Prognostic Value of Baseline GFR for Long Term Renal Function in Patients Undergoing Heart Transplant (HTX) (2011) (1)
Acoustic Analysis of a Continuous-Flow Left Ventricular Assist Device before and after Suspected Pump Thrombosis (2016) (1)
Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy (2022) (1)
High-density substrate and activation mapping of epicardial ventricular tachycardia during left ventricular assist device implant (2020) (1)
Development of De Novo Aortic Insufficiency in Patients with HeartMate 3. (2020) (1)
Risk of Post-Transplant Renal Dysfunction Is Increased in Patients Supported with Continuous-Flow Left Ventricular Assist Devices (2016) (1)
192 Psychosocial Evaluation before Left Ventricular Assist Device Implantation Can Predict Device Complication during Support (2011) (1)
Novel Minimally Invasive Surgical Approach for Refractory Cardiogenic Shock: A Hemodynamic Comparison With Current Percutaneous Strategies (2018) (1)
Implantation of Biventricular Circulatory Support with the Levitronix CentriMag in Patients with Acute ST-Elevation Myocardial Infarction (STEMI) and Refractory Cardiogenic Shock (2008) (1)
The Use of Cardiac Resynchronization Therapy in Patients Supported By Continuous-Flow Left Ventricular Assist Device (2015) (1)
In-situ Composition of Valved-Conduit for Complex Reoperative Aortic Root Replacement. (2020) (1)
Estimation of Total Cardiac Output Using Non-Invasive Parameters in HeartMate 3 Patients (2021) (1)
Trends in Simultaneous Heart-Kidney Transplantation: An Analysis of UNOS/OPTN Data from 2000 to 2015 (2017) (1)
Modulation of LV Loading and Arterial Pulsatility Affects PET/CT Coronary Flow Reserve in Continuous Flow LVAD Patients (2015) (1)
Response to Letter Regarding Article “Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation” (2012) (1)
Reduction of Drive Line Infection in Continuous Flow Assist Devices: Use of Standard Kit Including Silver Dressing and Anchoring Device (2014) (1)
Surgical ablation of atrial fibrillation: Clinical results and predictors of success (2003) (1)
Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3 (2021) (1)
Dynamics of Galectin-3 Levels Following Left Ventricular Assist Device Implantation (2013) (1)
The Clinical Importance of Functional Mitral Regurgitation and Atrial Fibrillation in Patients with Left Ventricular Assist Device. (2020) (1)
Special Considerations for Durable Left Ventricular Assist Device Use in Small Patients. (2022) (1)
The Weight is Over...Obesity Does Not Adversely Affect Venoarterial Extracorporeal Membrane Oxygenation Outcomes (2021) (1)
(348) - Hemodynamic Effects and Clinical Response to Intra-Aortic Balloon Pump in Chronic Heart Failure Patients with Cardiogenic Shock (2017) (1)
The Impact of Age, Sex, Therapeutic Intent and Severity of Advanced Heart Failure on Outcomes in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3 (Momentum 3) Pivotal Trial (2017) (1)
Surgical Management of Chemotherapy-Induced End-Stage Heart Failure (2010) (1)
Current technology: devices available for destination therapy. (2011) (1)
(607) - Red Cell Distribution Width Predicts 1-Year Mortality Following Heart Transplantation (2017) (1)
Correlation Between Aortic Valve Protein Levels and Vector Flow Mapping Of Wall Shear Stress And Oscillatory Shear Index in Patients Supported with Continuous-Flow Left Ventricular Assist Devices (2022) (1)
Alloantibody Desensitization Therapy in Bridge-to-Transplant Patients on Continuous-Flow Left Ventricular Assist Device Support (2016) (1)
Abstract 3376: The Outcomes and Costs of Intracorporeal and Extracorporeal Left Ventricular Assist Devices: An Analysis of the Centers for Medicare and Medicaid Services Database (2009) (1)
220: Improvement in Survival with Implantation of Levitronix CentriMag Biventricular Circulatory Support in Patients with Acute ST-Elevation Myocardial Infarction (STEMI) and Refractory Cardiogenic Shock (2009) (1)
581 Physical Therapy for Patients with External Ventricular Assist Device (2012) (1)
Relationship Between Speed and Left Ventricular Size in HVAD Patients: Lessons from the HVAD Ramp Test Study (2014) (1)
Estimation of Mean Arterial Pressure in HeartMate II Patients Using Doppler Blood Pressure and Pump Speed (2018) (1)
Endotoxaemia during left ventricular assist device insertion: relationship between risk factors and outcome. (2017) (1)
Re-dosing of del Nido cardioplegia in adult cardiac surgery requiring prolonged aortic cross-clamp (2021) (1)
Subcostal vs. Sternotomy Device Exchanges: Comparison of Long-Term Mortality and Re-Exchange (2014) (1)
Sex Differences in Characteristics and Outcomes Following HeartMate 3 Left Ventricular Assist Device Implantation. (2020) (1)
Cardiac Allograft Vasculopathy in HIV-Infected Patients (2013) (1)
Outcomes of Patients Bridged with Acute Mechanical Circulatory Support Devices to HeartMate 3. (2020) (1)
Effect of Body Mass Index on Outcomes of Heart Transplant Candidates Supported by Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2016) (1)
HeartMate II Device Exchange: Single Center Experience (2013) (1)
Incidence and Cause of Persistent Low Flow Alarm after HeartMate 3 Left Ventricular Assist Device Insertion. (2020) (1)
The Proportion of BNP Decline after Left Ventricular Assist Device Implantation Predicts Length of Survival after Surgery (2010) (1)
Evolution of Status 1A Heart Transplant Candidates (2015) (1)
TCT-177 Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support Following Durable Left Ventricular Assist Device Insertion (2018) (1)
Cyclin A2 Mediates cardiomyocyte regeneration in infarcted myocardium and preserves ventricular function (2004) (1)
Usefulness of a Multipronged Strategy to Prevent Device Thrombosis in HeartMate II Left Ventricular Assist Devices (2016) (1)
New strategies to expand the donor pool: are they misguided? (2004) (1)
OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT FOR REFRACTORY CARDIOGENIC SHOCK IN THE ERA OF MORE ADVANCED VENTRICULAR ASSIST DEVICES (2012) (1)
Abstract 13781: The Impact of Mechanical Unloading Through Ventricular Assist Device Placement on Cardiac ST2/IL-33 Signaling in Patients with Advanced Heart Failure (2011) (1)
Advanced Heart Failure Patients With Left Ventricular Assist Devices and Heart Transplantation Have Altered Oral Microbial Diversity Alongside Endotoxemia, Inflammation and Oxidative Stress (2018) (1)
HeartMate 3 Surgical Implant Technique and Outcomes in the MOMENTUM 3 Trial (2019) (1)
The Impact of Socioeconomic Status on Outcomes Following Left Ventricular Assist Device Implantation at a Single Center. (2020) (1)
Preoperative Screening Scale Predicts Successful Bridge to Transplantation among Chronic Congestive Heart Failure Patients (2006) (1)
Differential Effects of Carvedilol vs. Metoprolol on Mortality and Adverse Events in Left Ventricular Assist Devices Patients (2018) (1)
Temporary surgical ventricular assist device for treatment of acute myocardial infarction and refractory cardiogenic shock in the percutaneous device era (2021) (1)
Genotype-Guided Warfarin Dosing in Continuous-Flow Left-Ventricular Assist Device (CF-LVAD) Patients (2016) (1)
Mechanical circulatory support devices--state of the art. (2002) (1)
Myocardial Microvascular Density Increases After Chronic Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support (2014) (1)
Early and Late Outcomes of Subcostal Exchange of HeartMate II Left Ventricular Assist Device: A Word of Caution (2018) (1)
112: The Association between Metabolic Syndrome and Long-Term Survival in Patients Undergoing Orthotopic Heart Transplantation (2010) (1)
Abstract 18591: Relationship Between Gut Microbiota, Inflammation and Congestion Among Advanced Heart Failure Patients (2017) (1)
Transplant Versus VAD: Evolving and Future Perspectives (2014) (1)
C-Reactive Protein Levels Predict Outcomes in Continuous-Flow Left Ventricular Assist Device Patients: An INTERMACS Analysis (2021) (1)
523: Higher Rates of Co-Morbidities Post Cardiac Retransplantation Contribute to Decreased Survival (2008) (1)
When to use central mechanical support devices (2020) (1)
Impact of Heart Failure Drug Therapy on GI Bleeding Rates in LVAD Recipients: An INTERMACS Analysis. (2020) (1)
Regional Variation in Utilization of Hepatitis C-Positive Organs for Heart Transplantation in the United States (2019) (1)
Feasibility of temporary biventricular pacing after off-pump coronary artery bypass grafting in patients with reduced left ventricular function. (2013) (1)
559 Increased Blood Pressure Variability in Patients Supported by Continuous Flow Left Ventricular Assist Devices: A Novel Vascular Phenotype in the Absence of Pulsatility? (2012) (1)
Warfarin Sensitive Patients Have Higher Risk of Gastrointestinal Bleeding and Device Thrombosis on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support (2016) (1)
559: Feasibility of BiVAD Support with Membrane Oxygenation (2010) (1)
Partial Pulmonary-Right Heart Oxygenator (PROxy) Support System: A Novel Strategy for Management of Severe Pulmonary Hypertension (2015) (1)
99: Is native cardiac recovery sustainable following successful ventricular assist device support in cardiogenic shock post acute myocardial infarction? (2007) (1)
Discontinuing Amiodarone Treatment Prior to Heart Transplant May Lower Incidence of Severe Primary Graft Dysfunction (2018) (1)
Increased Right Ventricular Assist Device (RVAD) Utilization in Patients with HeartMate 3 Left Ventricular Assist Device (LVAD) in the Post-Approval Era. (2020) (1)
Predictors of 1‐year outcome after cardiac re‐transplantation: Machine learning analysis (2022) (1)
The Location of Intractable Ventricular Arrhythmias Following Left Ventricular Assist Device Implantation (2015) (1)
Outcomes of mechanical support for cardiogenic shock associated with late cardiac allograft failure (2020) (1)
(460) - Cardiac Resynchronization Therapy Reduces Mortality and Cardiovascular Readmissions in Left Ventricular Assist Device Recipients (2017) (1)
Impairment of Myocardial Endocannabinoid Signaling and Depletion of the Endogenous Ligands Anandamide and Arachidonoylglycerol in Patients with Advanced Heart Failure (2011) (1)
INCREMENTAL COST OF RIGHT VENTRICULAR FAILURE AFTER LEFT VENTRICULAR ASSIST DEVICE PLACEMENT (2011) (1)
Right heart failure following left ventricular assist device implantation (2005) (1)
Angiotensin Receptor Neprilysin Inhibition in Patients with Left Ventricular Assist Devices. (2020) (1)
Pneumonia in the First Year after Heart Transplant: Epidemiology, Risk Factors, and Effect on Survival (2010) (1)
Pulmonary Artery Pulsatility Index (PAPi) is a Predictor of Right Ventricular Assist Device (RVAD) Use Following HeartMate 3 LVAD Implantation. (2020) (1)
Advantages of a navigation system to create portals for shoulder arthroscopy: a preliminary investigation (2008) (1)
Considerations for referral: What happens to patients after being turned down for LVAD therapy. (2020) (1)
Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach. (2022) (1)
The Role of Serial Right Heart Catheterization Survey in Patients Awaiting Heart Transplant on Ventricular Assist Device (2021) (1)
Wait List Outcomes of Pediatric Patients Bridged to Heart Transplantation on the CF-LVADs Left Ventricular Assist Device (2014) (1)
Reduced myocardial blood flow during left ventricular assist device support may lead to premature closure of coronary artery bypass grafts (2003) (1)
EFFICACY OF PRIMARY SURGICAL VERSUS MEDICAL INTERVENTION FOR TREATMENT OF LEFT-SIDED INFECTIVE ENDOCARDITIS. (2020) (1)
Post-Transplant Outcomes of Pediatric Patients Bridged with Continuous Flow Left Ventricular Assist Devices (2014) (1)
363 Continuous-Flow LVAD Destination Therapy Versus Orthotopic Heart Transplantation in Patients above 65 Years of Age (2011) (1)
(600) - Pulmonary Vascular Resistance Is Not an Independent Predictor of Post-Transplant Outcome in Bridge-to-Transplant Patients; It's Time to Re-Evaluate Our Current Heart Transplant Eligibility (2017) (1)
Early Clinical Experience with Impella 5.5 at a Large Tertiary Care Center (2021) (1)
Abstract 19448: Ventricular Arrhythmias in Patients Following Continuous Flow Left Ventricular Assist Device Implantation (2012) (1)
Aspirin Responsiveness Predicts Mucosal Bleeding Events in Patients with Continuous-Flow Left Ventricular Assist Devices (2016) (1)
Aortic Insufficiency and Clinical Outcomes in Patients Undergoing Aortic Valve Procedures at the Time of Continuous Flow Left Ventricular Assist Device Implantation (2013) (1)
Bridge to Transplant with Continuous Flow Left Ventricular Assist Devices Increases Risk for Severe Primary Graft Dysfunction (2018) (1)
Contemporary Outcome of Unplanned Right Ventricular Assist Device for Severe Right Heart Failure After Continuous Flow Left Ventricular Assist Device Insertion (2016) (1)
Infection in permanent circulatory support: experience from the randomized evaluation of mechanical assistance in the treatment of congestive heart failure (rematch) trial (2003) (1)
Digoxin is Associated with Decreased Survival Free from Hemocompatibility-Related Adverse Events in LVAD Patients - A Propensity Score Matched Analysis (2019) (1)
TCT-758 Age Alone Should Not Preclude Surgery: Contemporary Outcomes after Aortic Valve Replacement in Nonagenarians (2013) (1)
Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study. (2020) (1)
Outcomes of Medicare beneficiaries with ventricular assist devices. (2009) (1)
Assessment of myocardial blood flow and coronary bypass graft patency during LVAD support (2003) (1)
Protective effects of complement blockade in an isograft model of lung preservation and transplantation (1996) (1)
Experimental Venous Congestion Causes Peripheral Release of Angiopoietin-2 and Tissue Necrosis Factor-α - A New Insight into the Pathophysiology of Gastrointestinal Bleeding in CF-LVAD Patients (2019) (1)
Serum-Derived Exosomal Proteome Analysis of Patients With Heart Failure and After Heart Transplantation (2015) (1)
Cardiac Arrest in the Era of Mechanical Circulatory Support: A Single Center Experience with Extracorporeal Cardiopulmonary Resuscitation (2014) (1)
513: One Year Followup with a Continuous Flow LVAD as a Bridge to Heart Transplantation (2008) (1)
580 Transplanting high‐risk recipients with marginal donor hearts is clinically effective (2008) (1)
Left-Ventricular Assist Device Is Associated with Elevated Serum Levels of Natural IgG Reactive to Apoptotic Cells and Oxidized Epitopes (2016) (1)
PREOPERATIVE MALNUTRITION IS ASSOCIATED WITH POOR CLINICAL OUTCOMES IN PATIENTS UNDERGOING LEFT VENTRICULAR ASSIST DEVICE (LVAD) IMPLANTATION (2004) (1)
Low INTERMACS Profiles: One-Stage Durable LVAD Implantation for INTERMACS Level 1: Indications and Contraindications (2017) (1)
VA-ECMO Cannulation Strategy and Influence on Cerebral Blood Flow Velocities (2018) (1)
193 The Incremental Cost of Complications after Left Ventricular Assist Device Placement (2011) (1)
Natural Polyreactive Antibodies and Inflammatory Markers Following Left Ventricular Assist Device Implantation (2018) (0)
549: Additional Procedure to Aortic Valve at LVAD Placement (2010) (0)
ROLE OF AN ABIOMED FOR SHORT-TERM SUPPORT AND BRIDGE TO TRANSPLANTATION: THE COLUMBIA PRESBYTERIAN EXPERIENCE (2003) (0)
105: Tight perioperative glucose control is associated with fewer LVAD related infections and better post-VAD survival (2006) (0)
Abstract 18827: Left Ventricular Assist Devices and Heart Transplantation Reduces Gut Dysbiosis, Endotoxemia, Inflammation and Oxidative Stress in Advanced Heart Failure Patients (2017) (0)
Mechanical Unloading Via Left Ventricular Assist Device Implantation Ameliorates Adipose Tissue Inflammation and Increases Adipocyte Size in Patients With Advanced Heart Failure (2011) (0)
BONE MORPHOGENIC PROTEIN-1/TOLLOID-LIKE METALLOPROTEINASE UPREGULATION PROFILE IN HUMAN AND MURINE ISCHEMIC HEART FAILURE (2019) (0)
Pulsatility and Flow Patterns across Macro- and Microcirculatory Arteries of Continuous-Flow Left Ventricular Assist Device Patients. (2023) (0)
Recipient and Donor Risk Factors Associated with Primary Graft Failure Requiring Temporary Mechanical Circulatory Support < 24 Hours After Heart Transplantation (2016) (0)
Abstract 20507: Increased Adipocytokine Signaling in Patients with Advanced Heart Failure Corrects after Mechanical Unloading through Ventricular Assist Device Implantation (2010) (0)
654 Outcome of Patients with Postcardiotomy Shock Requiring Ventricular Assist Device Support Remains Poor (2011) (0)
Feasibilityof smaller arterial cannulas invenoarterial extracorporeal membrane oxygenation (2015) (0)
De Novo Aortic Insufficiency on Left Ventricular Assist Device Support: An Analysis of the INTERMACS Registry (2018) (0)
Mechanical Circulatory Support for Late Cardiac Allograft Failure (2018) (0)
Wall Shear Stress in the Middle Cerebral Artery of HM II Patients - A Prospective, Mechanistic Study Using Vector Flow Mapping (2019) (0)
Successful Use of Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridging Strategy in INTERMACS 1 Patients Undergoing HeartMate 3 LVAD Implantation. (2020) (0)
The Use of Hypothermic Circulatory Arrest During Heart Transplantation Does Not Worsen Posttransplant Survival. (2016) (0)
Linear ethanol jet injections for surgical treatment of atrial fibrillation: Canine survival study (2003) (0)
Longitudinal Trends in Gut Microbial Community Diversity among HF Patients Undergoing LVAD (2019) (0)
(1314) - Circadian Variation in Hemodynamics and Device Parameters in HeartMate II Patients (2017) (0)
341 Effects of forskolin, phorbol ester and epidermal growth factor (EGF) on prolactin (PRL) production by human decidual cells. (1989) (0)
MELD XI Successfully Predicts Thirty Day Mortality in Patients Who Received Centrimag VAD for Acute Decompensated Heart Failure (2015) (0)
308: Serum Albumin Concentration as Predictor of Mortality in Patients with End Stage Heart Failure Treated Medically and with Mechanical Circulatory Support – Analysis of the UNOS/OPTN Data and the DT Thoratec Registry – Years 1999-2007 (2009) (0)
Ten-year Experience With CentriMag Ventricular Assist Device Use in Acute Myocardial Infarction and Cardiogenic Shock (2018) (0)
Abstract 13311: Low Serum Albumin Concentration is Associated With Poor Post-Transplant Prognosis in Patients Undergoing Heart Transplantation (2011) (0)
16: Dynamics in Lipid Profile Subfractions in Patients Undergoing Cardiac Transplantation (2010) (0)
Cystatin C is Superior to Creatinine for Prediction of Adverse Events in Heart Failure Patients Undergoing LVAD Implant (2019) (0)
Redo heart transplantation (columbia experience) (2012) (0)
Abstract 982: RAGE Modulates Vascular Remodeling: Critical Contribution of BM Progenitors and Local Cells of the Vessel Wall (2006) (0)
(670) – Prospective Evaluation of Urine Dipstick for Detection of Moderate and Severe Hemolysis in Outpatients on CF-LVAD Support (2017) (0)
Usefulness of Near-infrared Reflectance Spectroscopy to Assess Lower-limb Perfusion on Femoral Veno-arterial Extracorporeal Membrane Oxygenation (2018) (0)
Strong Correlation Between Alere Home INR and Core Lab INR in Patients Supported with CF-LVAD (2014) (0)
Heart transplantation in diabetic recipients: a decade review of 161 patients at columbia presbyterian (2003) (0)
Increased Donor Selectivity Does NOT Decrease Primary Graft Failure After Heart Transplantation (2016) (0)
106 Serial Echocardiographic Evaluation Using 2-Dimensional Speckle Tracking Imaging in Monitoring Right Ventricular Failure Development Following Left Ventricular Assist Device Implantation (2012) (0)
Novel Minimally Invasive Surgical Approach Using External Ventricular Assist Device and Extracorporeal Membrane Oxygenation in Refractory Cardiogenic Shock (2016) (0)
Clinical Characteristics and Outcomes of Cancer Survivors Undergoing Heart Transplantation (2021) (0)
Incidence of Deep Venous Thrombosis and its Impact on Outcomes after Heart Transplantation (2021) (0)
Micro-RNA-451 and Measures of Hemolysis Associated with Left Ventricular Assist Device Implantation (2013) (0)
1-Year Graft Function and Hemodynamics in Heart Transplant Patients Who Experienced Severe Primary Graft Dysfunction (2019) (0)
Abstract 18562: Severity of Posterior Coaptation Displacement of the Anterior Mitral Leaflet Contributes to Irreversibility of Mitral Regurgitation Following Left Ventricular Assist Device Placement (2012) (0)
Reduced Long-term Outcomes after Orthotopic Heart Transplantation in Septuagenarians (2014) (0)
(392) – Attenuation of Cardiac Allograft Vasculopathy in Dual Organ Transplantation (2017) (0)
A CASE OF CHOLANGIOCARCINOMA ASSOCIATED WITH LOCALIZED BILIARY DILATATION AND HEPATOLITHIASIS -OBSERVATION FOR 5 YEARS- (1992) (0)
Incidence and Outcomes of Cardiac Surgery After Orthotopic Heart Transplantation (2018) (0)
Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices (2019) (0)
Occurrence and Clinical Patterns of Stroke Based on Arterial Cannulation Strategy during Veno-Arterial Extracorporeal Membrane Oxygenation Support (2019) (0)
(198) – Circadian Variation of Blood Pressure and Hemodynamics in Outpatients with Heart Mate II (2017) (0)
(1350) - Concomitant Tricuspid Valve Replacement with a Continuous-Flow Left Ventricular Assist Device in Patients with Severe Tricuspid Regurgitation and Marginal Right Ventricular Function (2017) (0)
Pre-LVAD Blood-Borne Infection is a Harbinger of Poor Prognosis after LVAD Implantation (2019) (0)
243: Survival in Men and Women with Left Ventricular Ejection Fraction Lower Than 30% Referred for Orthotopic Heart Transplantation (2008) (0)
Serum Cystatin C versus Creatinine Based Assessment of Renal Function in Heart Transplant Patients. (2020) (0)
Microbiome-Derived TMAO Exhibits No Protective Effect against GIB in LVAD Patients (2019) (0)
487 Trends in Health Disparities among Left Ventricular Assist Device Recipients in the United States: An Analysis of the Centers for Medicare and Medicaid Services Database (2011) (0)
Pre-Operative Renal Disease Progressively Impacts Long-Term Survival Following Aortic Valve Surgery (2014) (0)
74 Pre- and Post-Operative Risk Factors Associated with Neurological Complications in Patients Supported by Ventricular Assist Device (2011) (0)
Mechanical unloading leads to echocardiographic, electrophysiological, histological and serological recovery (2004) (0)
HIGH PREVALENCE OF BLEEDING WITH CONTINUOUS FLOW DEVICES (2010) (0)
Elevated Outpatient C-Reactive Protein Independently Predicts All-Cause Mortality in LVAD Recipients. (2020) (0)
Utilization of Mechanical Circulatory Support Devices and Impact on Outcomes in the New Heart Allocation System: An Analysis of the UNOS Registry. (2020) (0)
467 Generally Accessible Echocardiographic Parameters of Left Heart Could Predict Right Heart Failure after Left Ventricular Assist Device Implantation (2011) (0)
Abstract 13929: Mechanical Unloading Through Left Ventricular Assist Device Implantation Reduces Endoplasmic Reticulum Stress and Improves Calcium Handling in Patients With Advanced Heart Failure (2013) (0)
HeartMate II Risk Score (HMRS) and MELD-Xi Scores Do Not Predict Mortality in HeartMate 3 LVAD Patients. (2020) (0)
Outcomes of Patients Complicated With Late Right Heart Failure During Continuous Left Ventricular Device: Support: Should Patients Stay on Device or Be Transplanted? (2015) (0)
Abstract 2363: Longer Duration of Continuous Flow Ventricular Assist Device Support Predicts Greater Hemodynamic Compromise with Return to Pulsatility (2006) (0)
Outcomes of treatment for deep left ventricular assist device infection. (2022) (0)
TCT-489 Use of a Percutaneous Left Ventricular Assist Device for Patients with Cardiogenic Shock (2018) (0)
Stromal-Derived Factor-1 (SDF-1) Expression is Downregulated After Chronic Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support (2014) (0)
Deep Sequencing Reveals Dynamics in Circulating miRNAs Following Heart Transplantation (2015) (0)
Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices. (2020) (0)
1050-121 Echocardiographic, electrophysiological, histological, and serological recovery during left ventricular assist device support (2004) (0)
453 The Prevalence of Chronic Kidney Disease before and after Orthotopic Heart Transplant: Does the Degree of eGFR Decline Proportionally Translate into Poorer Patient Outcomes? (2012) (0)
366 Pre-Transplant MELD-XI Scores Predict Long-Term Survival after Orthotopic Heart Transplantation (OHT) in the UNOS Registry (2011) (0)
Sex-Based Outcomes of Heart Re-Transplantation: Analysis from UNOS Database (2021) (0)
Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support: Invited commentary (2004) (0)
Five -Fold Increase in Antibody-Mediated Rejection (AMR) Post-Heart Transplant in Patients Developing Allosensitization During Left Ventricular Assist Device Support (LVAD) (2014) (0)
Incidence and Predictors of Left Ventricular Functional Recovery on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support (2016) (0)
Prospective, Multicenter Study of Ventricular Assist Device Infections Heart (2013) (0)
330: Blood Product Requirements during Heart Transplantation Are Significantly Higher in Patients Bridged with Continuous Flow Devices Compared to Pulsatile Flow Devices (2010) (0)
Increasing Use of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation (2014) (0)
Aortic Insufficiency Following Heartmate 3 Implant in Patients on Temporary Mechanical Circulatory Support (2021) (0)
Change in Mitral Valve Geometry after Left Ventricular Assist Device Implantation in Patients with Functional Mitral Regurgitation. (2020) (0)
1050-126 Left ventricular assist device implantation in patients with viral myocarditis-induced heart failure (2004) (0)
A Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices (2018) (0)
Mechanical Circulatory Support as a Bridge to Transplantation (2013) (0)
Abstract 21416: Variation Across Centers and Predictors of Initial Immunosuppression Strategy After Heart Transplant (2017) (0)
Outcome of Patients Having Multiple Mechanical Circulatory Support Devices before Orthotopic Heart Transplantation (2016) (0)
Abstract 15634: Effect of Perioperative Atrial Fibrillation in Orthotopic Heart Transplant Recipients on Short and Long Term Mortality (2011) (0)
Abstract 13864: Bridging Cardiogenic Shock Patients with Short Term Ventricular Support at a Community Hospital to Long Term Ventricular Support at a Tertiary Hospital - Feasibility and Outcome. (2011) (0)
TRANSFUSION OF RED BLOOD CELLS: THE IMPACT ON SURVIVAL AFTER AORTIC VALVE REPLACEMENT AT TEN-YEAR FOLLOW-UP (2014) (0)
Reduced 24-hour Blood Pressure Variability is Associated With Lower Pulse Pressure in Patients on Continuous Flow Left Ventricular Assist Device Support (2018) (0)
403: The effect of body mass index on survival following heart transplantation: A critique of the ISHLT’s revised listing criteria for heart transplantation (2007) (0)
The Evolving Role of Mechanical Circulatory Assistance in the Management of Heart Failure (2002) (0)
Cardiac Donor Characteristics Predictive of One Year Post-Heart Transplant Mortality: Analysis of the UNOS Transplant Database (2015) (0)
Stroke following left ventricular assist device implantation increases length of stay but does not decrease survival (2005) (0)
High Mortality With Acute Kidney Injury After Mechanical Support for Cardiogenic Shock (2015) (0)
Clinical Impact of Hematoma Expansion in Left Ventricular Assist Device Patients. (2020) (0)
Use of Circulatory Arrest During Heart Transplantation Does Not Worsen Perioperative Survival (2015) (0)
Abstract 16747: The Artificial Pulse of the HeartMate3 LVAD Alters Mean Arterial Pressure Calculation, and the Relationship Between Arterial Pulse Pressure and Pulsatility Index (2020) (0)
248 Studies on the Role of Epidermal Growth Factor (EGF) in human Endometrial Decidualization. (1989) (0)
536 Reduced Antithrombotic Therapy as an A Priori Strategy in HM II Recipients: A Word of Caution (2012) (0)
Mechanical Circulatory Assistance As a Bridge to Transplantation (2004) (0)
Associations among Biomarkers of Congestion, Inflammation and Oxidative Stress in Heart Failure, LVAD and Heart Transplant (2019) (0)
Natural Antibodies and Left Ventricular Assist Device Complications. (2020) (0)
Elevated Outpatient C-Reactive Protein Independently Predicts Stroke and Gastrointestinal Bleeding in LVAD Patients. (2020) (0)
327 Specific binding of Vasoactive intestinal polypeptide (VIP) to decidual cells and its effects on the prolactin production. (1990) (0)
Hepatic Dysfunction and MELD Score Improve After Orthotopic Heart Transplantation and Predict Post-Transplantation Mortality (2010) (0)
TCT-133 Use of a Micro-axial Percutaneous Left Ventricular Assist Device (pLVAD) for Patients with Cardiogenic Shock. (2016) (0)
Mechanical Unloading through Ventricular Assist Devices Increases Myocardial Content of Unsaturated Acyl-CoA Species in Patients with Advanced Heart Failure (2013) (0)
Clinical Outcomes After Tricuspid Annuloplasty Prior to Cardiac Transplantation: A Single Center Experience (2018) (0)
Non-Invasive Estimation of Pulse Pressure in HeartMate 3 Patients (2021) (0)
Peripheral vascular disease adversely affects survival for cardiac transplant recipients (2004) (0)
Mechanisms of Antibody Mediated Rejection in the Absence of Donor Specific Antibodies (2019) (0)
Post-Transplant Outcomes of Patients Initially Receiving Left Ventricular Assist Device as Either Bridge to Candidacy or Destination Therapy (2018) (0)
Pre-Transplant Estimated Glomerular Filtration Rate Less Than 40 Provides Similar Risks of Post-transplant Mortality Both in LVAD and Non-LVAD Heart Transplant Recipients (2018) (0)
Erratum: Endotoxaemia during left ventricular assist device insertion: relationship between risk factors and outcome (British Journal of Anaesthesia (2004) 92(1) (131–133)(S0007091217362396)(10.1093/bja/aeh010)) (2017) (0)
A CASE OF GIANT MUCINOUS CYST ADENOMA IN THE SACROCOCCYGEAL REGION (1992) (0)
Infectious Complications after Cardiac Transplantation in Patients Bridged to Transplantation with Mechanical Circulatory Support Devices Versus Medical Therapy (2016) (0)
Combined Therapy of Ventricular Assist Device and Extracorporeal Membrane Oxygenator for Profound Acute Cardiopulmonary Failure (2016) (0)
Ability to Obtain Blood Pressure Readings By Standard Automated Blood Pressure Monitor Helps Interpreting the Relationship Between Doppler Blood Pressure to Systolic Blood Pressure and Mean Arterial Pressure (2015) (0)
SHORT-TERM WAITING LIST SURVIVAL WITHOUT SUPPORT BY A VENTRICULAR ASSIST DEVICE (2010) (0)
755 Reduced Handgrip Strength as a Marker of Patient Frailty Predicts Worse Survival after Implantation of a Left Ventricular Assist Device (2012) (0)
(581) - Bridge-to-Transplant LVAD or Primary Heart Transplantation in Young Patients? Both Offer Similar Mid-Term Survival (2017) (0)
247 Effects of Adenosie Human Decidual Prolactin (PRL) Production (1991) (0)
(1308) – The Short-to-Shield Phenomenon in Heartmate II Left Ventricular Assist Devices: A Single Center Experience (2017) (0)
Myocardial Protection During Left Ventricular Assist Device Implantation (2007) (0)
Images in Cardiovascular Medicine Ventricular Assist Device-Associated Thrombus (2011) (0)
Effect of myocardial revascularization on left ventricular systolic function in patients with heart failure (2006) (0)
Left Ventricular, Biventricular and Total Artificial Heart Support are Associated with Similar Levels of Allosensitization in Bridge-to-Transplant Patients: An Analysis of the UNOS Database (2016) (0)
Effects of ACE Inhibitors, Angiotensin Receptor Blockers and Angiotensin Receptor-Neprilysin Inhibitors on Survival Free from Gastrointestinal Bleeding in HeartMate 3 Patients - A Marginal Structural Modeling Analysis (2021) (0)
The Clinical Impact of Ventricular Arrhythmias Following Continuous Flow Left Ventricular Assist Device Implantation (2013) (0)
584 Pneumonia in the First Year Post-Cardiac Transplant Is Common and Associated with Reduced Long Term Survival (2011) (0)
Palliative Care Consultation in Cardiogenic Shock Requiring Short-term Mechanical Circulatory Support- A Retrospective, Description of Timing and Utilization From a Single Institution (2018) (0)
TRANSVALVULAR INTRA-AORTIC VENTRICULAR ASSIST DEVICE ACHIEVES FUNCTIONAL CARDIAC IMPROVEMENT IN COMPUTER HEART FAILURE MODEL (2005) (0)
Novel Approach to Assess Intraventricular Pressure Difference in Patients with Left Ventricular Assist Device during Ramp Study (2019) (0)
Durability and Clinical Impact of Tricuspid Valve Procedures in Patients Receiving Continuous-Flow Left Ventricular Assist Device (2015) (0)
Use of Serum Cystatin C versus Creatinine for Estimation of Renal Function and Valganciclovir Dosing in Heart Transplant Recipients. (2020) (0)
465 Mechanical Unloading through Ventricular Assist Device Implantation Corrects Adiponectin Resistance in Patients with Advanced Heart Failure (2011) (0)
SY-4-6 Surgical Treatment of Advanced Heart Failure : The Current Strategy at Columbia University : Improving Success With Heartmate Left Ventricular Assist Device As A Bridge To Transport (2004) (0)
Effects of Surgical Left Ventricular Vent in Patients with Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation (2021) (0)
Comparison of Heart Replacement Therapy in Patients Over 65 Years Old (2014) (0)
069 - Characterizing Robust Hemodynamic Response to IABP Therapy in Chronic Heart Failure Patients with Cardiogenic Shock: Can We Identify IABP Super-Responders? (2017) (0)
Effect of Methylene Blue Administration on Vasoplegia Following Left Ventricular Assist Device Implantation (2019) (0)
Abstract 854: Homing of Fetal Stem Cells to Damaged Maternal Hearts: A Potential Mechanism for Cardiac Repair in Peripartum Cardiomyopathy (2007) (0)
Pre-Transplant Hemoglobin A1c Predicts Long Term Outcomes Following Heart Transplantation (2018) (0)
364 Increased Vascular Expression of the Proinflammatory Adhesion Molecules VCAM and E-Selectin and Endothelial Depletion of vWF Following Continuous Flow Left Ventricular Assist Device Placement (2012) (0)
Hemolysis, Device Thrombosis, and Risk of CVA in HM II: Patients: Role of Watchful Waiting? (2015) (0)
Late-onset T-cell activation and cardiac allograft rejection following cessation of daclizumab induction therapy (2005) (0)
Prognostic Implications of Intermediate Hemolysis in Continuous Flow Left Ventricular Assist Device Patients (2018) (0)
(887) - Mechanical Circulatory Support Devices (MSCD) Therapy in the Era of the Affordable Care Act (ACA): National Trends in Hospitalization Costs and In-Hospital Mortality (2017) (0)
IMPACT OF THE REVERSAL OF ELEVATED PULMONARY VASCULAR RESISTANCE WITH LEFT VENTRICULAR ASSIST DEVICE OR CHRONIC VASODILATORS ON POST HEART TRANSPLANT CLINICAL OUTCOMES (2020) (0)
SCAI Shock Classification to Predict Outcomes of Venoarterial Extracorporeal Membrane Oxygenation (2021) (0)
Presence of Left Atrial or Left Ventricular Thrombus at the Time of CF-LVAD Implantation is Associated with Increased Post-Operative Risk of Stroke or Death (2019) (0)
210 Impact of Continuous Versus Pulsatile Unloading Pattern on Myocardial Matrix Biomarkers in Patients with Left Ventricular Assist Device (2011) (0)
Discharge Lactate Dehydrogenase (LDH) Level Predicts Early Device Thrombosis in Patients with HEARTMATE II Left Ventricular Assist Devices: A Retrospective Cohort Analysis (2016) (0)
Residual Lung Injury Following HeartMate 3 Explantation for Heart Transplant. (2020) (0)
Dynamics of Kidney Function Following Aortic Valve Replacement Using Ckd-Epi Based Gfr Estimation (2014) (0)
Abstract 18488: The Impact of Mechanical Circulatory Support Type for Bridge-to-Transplantation on Post-transplant Prognosis: An Analysis of the United Network for Organ Sharing (UNOS) (2012) (0)
Pre-Transplant Proteinuria Predicts Post-Transplant Renal Replacement Therapy and Mortality in Patients Bridged with Left Ventricular Assist Devices (2018) (0)
Driveline Infection in LVAD Patients: Effect of Era, Pump Type and Treatment Strategy. (2020) (0)
Limitations of Preoperative Right Ventricular Failure Assessment in Patients Undergoing LVAD Insertion (2019) (0)
47 Parametric Prediction Model Using Preoperative Serum Albumin Concentration for Survival Estimation in Patients Undergoing Heart Transplantation (2012) (0)
217 Risk-Stratification of Heart Transplant (HTX) Candidates with Advanced Liver Dysfunction (2011) (0)
Outcomes in Smaller Body Size Adults after HeartMate 3 Left Ventricular Assist Device Implantation. (2022) (0)
Abstract 19732: Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance and Normalizes Cardiac Metabolism in Advanced Heart Failure (2010) (0)
RNA Expression Analysis of Antibody Mediated Rejection after Heart Transplant with or without Donor Specific Antibodies. (2020) (0)
527 Analysis of Impaired Liver Function through Different MELD Scores for Prediction of Long-Term Survival after Orthotopic Heart Transplantation (2011) (0)
10-Year Outcomes of Extracorporeal Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest at a Tertiary Center (2019) (0)
(469) – How Old Is Too Old? The Influence of Advanced Age on VA-ECMO Outcomes (2017) (0)
Hemolysis Does Not Lead to Increased Discordance between Measured APTT and ANTI-XA Levels in Patients with Continuous-Flow Left Ventricular Assist Devices (2016) (0)
Metabolic Vasoreactivity in the Middle Cerebral Artery of Heart Failure Patients with and without Continuous-Flow Left Ventricular Support (2019) (0)
3: UNOS status at the time of heart transplantation predicts long-term survival (2006) (0)
DIABETES MELLITUS DOES NOT WORSEN LONG-TERM SURVIVAL FOLLOWING ISOLATED SURGICAL AORTIC VALVE REPLACEMENT: A PROPENSITY MATCHED ANALYSIS (2016) (0)
Pre LVAD CPET as Predictor of INTERMACS Profile and Early Outcomes Post LVAD. (2020) (0)
A Comparison of Middle Cerebral Artery and Central Retinal Artery Hemodynamics in HM II Patients (2019) (0)
Abstract 3661: Equal Success, but Shorter Length of Stay, With Axial Versus Pulsatile Flow Left Ventricular Assist Devices (LVAD) as Bridge to Cardiac Transplantation (BTT): The Columbia Presbyterian Experience (2009) (0)
Effect of Mycophenolate Mofetil Dosing on 6-month Risk of Acute Cellular Rejection, Leukopenia and CMV Viremia in Heart Transplant (2021) (0)
Predictors of Readmission in Long-Term Continuous Flow Left Ventricular Assist Device Support (2016) (0)
(193) - Impact of Center Volume on Bridging to Transplantation with Contemporary Left Ventricular Assist Devices (2017) (0)
Survival in Cardiac Amyloid Using Extended Donor Organs in Comparison to Transplantation for Other Indications (2008) (0)
166 High Transpulmonary Gradient Obtained at the Time of LVAD Implantation Is Associated with Worse Long Term 1 Year Survival after Cardiac Transplantation (2012) (0)
Inflow or Outflow Obstruction Requiring Surgical Corrections Late after HeartMate 3 Left Ventricular Assist Device Insertion. (2020) (0)
Outcomes after Early Initiation of mTOR-Inhibitors in Adult Cardiac Transplant Recipients (2019) (0)
PREOPERATIVE HEPATIC INSUFFICIENCY CORRELATES WITH LONGER INTENSIVE CARE UNIT (ICU) STAYS AND LOWER BRIDGE TO TRANSPLANT RATES FOLLOWING LEFT VENTRICULAR ASSIST DEVICE (LVAD) INSERTION (2004) (0)
(588) – VA ECMO as a Bridge to Transplantation: Emergent Eligibility and Outcomes (2017) (0)
Predictors and Outcomes of Readmission After Heart Transplantation: An Analysis of UNOS/OPTN Data From 2000 to 2015 (2018) (0)
342: The Epidemiology of Bleeding and Clotting in Pulsatile and Continuous Flow LVAD Patients (2008) (0)
The Indication for Short Term Ventricular Assist Device Placement Influences Survival (2010) (0)
Effect of the 2006 U.S. Donor Heart Allocation Policy Change on Waitlist Complications and Post-Transplant Mortality Among Candidates Supported With Mechanical Circulatory Support (2015) (0)
Arrhythmia History Predicts Morbidity and Mortality Following LVAD Implantation (2016) (0)
Minimally Invasive versus Sternotomy Approach for Centrimag Biventricular Support in Refractory Cardiogenic Shock (2017) (0)
Abstract 2457: Left Ventricular Assist Device Therapy with the HeartMate II Continuous Flow Rotary Pump as a Bridge to Heart Transplantation (2007) (0)
Peri-Operative Serum Amiodarone Levels are Not Predictive of Graft Dysfunction in Orthotopic Heart Transplantation (2019) (0)
QRS Duration Predicts Outcomes Following Implantation of a Left Ventricular Assist Device (2016) (0)
(1363) - Use of Abciximab and Heparin Can Safely Facilitate LVAD Implantation in Patients with Heparin-Induced Thrombocytopenia (2017) (0)
Erratum to: Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure (2014) (0)
(1225) - Dose-Dependent Association Between Amiodarone and Primary Graft Dysfunction in Heart Transplantation (2017) (0)
(55) – Outcomes of Multiple Concomitant Valve Procedures in Patients Receiving Continuous-Flow Left Ventricular Assist Device (2017) (0)
(153) - Quality of Life and Functional Capacity Assessment in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3(Momentum 3) Pivotal Trial (2017) (0)
Pseudomonas aeruginosa Infection Predicts Need for Surgical Incision and Drainage in LVAD Patients with Driveline Infection (2021) (0)
Exploring Sex Differences in Gut Microbial Diversity, Endotoxemia, Inflammation and Oxidative Stress in Heart Failure, Left Ventricular Assist Device, and Heart Transplant Patients (2019) (0)
Long-Term Outcome of Cardiac Transplant After Continuous-Flow Left Ventricular Assist Device Support (2014) (0)
Invited commentary. (2006) (0)
Treatment of Congestive Heart Failure ( REMATCH ) Experience Heart Failure : The Randomized Evaluation of Mechanical Assistance for the Neurological Events During Long-Term Mechanical Circulatory Support (2004) (0)
The New Heart Allocation System: Implications on Patients with Restrictive Cardiomyopathy in the UNOS Registry (2017) (0)
585 Aspergillus Infection after Heart Transplantation: Risk Factors, Clinical Course and Outcomes (2011) (0)
Age is not a factor in survival of patients undergoing left ventricular assist device placement as destination therapy: The REMATCH experience (2003) (0)
Abstract 3131: Axial Flow LVADs are Associated with Fewer Device-Related Infections than Pulsatile LVADs (2006) (0)
ITO and IR potassium channel (K+) expression and regulation during severe left ventricular dysfunction (LVD) and ventricular unloading (2003) (0)
Feasibility of 24-Hour Advanced Ambulatory Blood Pressure and Hemodynamic Monitoring in Patients with Continuous-Flow Left Ventricular Assist Device (2016) (0)
463: RVSWI Is an Independent Predictor of Need for MCS and/or HT in Stable Outpatients with NYHA Class III HF (2010) (0)
282: A Single-Institutional 4-Year Experience Comparing HM II and HM I XVE as a Bridge to Transplant (2009) (0)
Outcome of Cardiac Retransplantation for Late Allograft Failure: A Fifteen-Year Single Center Experience (2018) (0)
471: Combined Heart Kidney Retransplant Has Lower Survival than De Novo Transplant (2010) (0)
Association of Plasma Trimethylamine-N-oxide and Serum Endothelin-1 with Cardiac Allograft Vasculopathy in Heart Transplant Recipients. (2020) (0)
Abstract 18438: Long Term Left Ventricular Assist Device as Bridge to Heart Transplantation -- is it Really a Bridge? (2010) (0)
EARLY LEFT VENTRICULAR ASSIST DEVICE (LVAD) IMPLANTATION IMPROVES BRIDGE TO TRANSPLANT RATE FOLLOWING POSTCAR-DIOTOMY CARDIOGENIC SHOCK (2004) (0)
Abstract 16687: The Incidence and Etiology of GI Bleeding in Patients Supported by Continuous Flow Left Ventricular Assist Device (2011) (0)
Abstract 19648: Exposure to Ionized Medical Radiation after Heart Transplant is Associated with Higher Risk of Malignancies (2012) (0)
After the Referral: How Patients Fare After Evaluation for Left Ventricular Assist Device Placement (2018) (0)
Serial Assessment of Magnetically Levitated Centrifugal-Flow LVAD Pump Position and Inflow Angle on Chest Radiograph and Effects on Adverse Events. (2020) (0)
Gut Microbial Diversity, Inflammation and Oxidative Stress is Associated with Tacrolimus Dosing Requirements Early after Heart Transplant (2019) (0)
Lack of Nocturnal Blood Pressure Reduction Increases the Risk of Stroke in Patients on Left Ventricular Assist Device Support. (2020) (0)
Comprar Surgical Treatment for Advanced Heart Failure | Jeffrey A. Morgan | 9781461469186 | Springer (2013) (0)
36 Right-to-Left Hemispheric Predominance of Cerebrovascular Lesions and Its Association with Systemic Infection in Patients Undergoing Left Ventricular Assist Device Implantation (2012) (0)
Placement of a Fully Magnetically Levitated Left Ventricular Assist Device: Intrathoracic versus Intrapericardial. (2020) (0)
Abstract 3772: Alternate Listing Transplantation is a Cost-Effective Treatment for End-Stage Heart Failure Patients (2007) (0)
Abstract 11930: Late Right Heart Failure During Continuous-Flow Left Ventricular Assist Device Support Adversely Affects Post-Transplant Outcome (2014) (0)
Contemporary Outcomes for Cardiogenic Shock Patients Bridged to Advanced Heart Therapies with Temporary Mechanical Circulatory Support (2021) (0)
Biomarkers of Inflammation and Oxidative Stress in HeartMate II vs HeartMate 3 Patients. (2020) (0)
Does Mechanical Circulatory Support Prior to Heart Transplantation Influence Early Onset of Coronary Allograft Vasculopathy (2013) (0)
Abstract 19327: Reduced Handgrip Strength Predicts Clinical Outcomes in Patients with Advanced Heart Failure Undergoing Ventricular Assist Device Placement (2012) (0)
Management of Acute Decompensated Heart Failure, Christopher M. O’Connor, Wendy Gattis Stough, Mihai Gheorghiade, Kirkwood F. Adams (Eds.). Taylor and Francis, London, United Kingdom (2005), 624 pp, illustrated, $229.95, ISBN: 1841843741 (2007) (0)
The Association of Sarcopenia with Gut Dysbiosis and Inflammation in Heart Failure, LVAD and Heart Transplant Patients (2021) (0)
(649) – Use of Pre-Device Exchange Computed Tomography Angiography for Left Ventricular Assist Device Thrombosis (2017) (0)
Post-Discharge Functional Capacity, Health-Related Quality of Life, Depression, Anxiety and Post-traumatic Stress Disorder in Patients Receiving a Long-term Left Ventricular Assist Device. (2021) (0)
Abstract 18940: Application of the HeartMateII Risk Score in Patients With Continuous Flow Left Ventricular Assist Devices (2013) (0)
Long-Term Outcomes in Continous-Flow Left Ventricular Assist Device Patients with and without ICD (2016) (0)
Evaluation of the DuraHeart® Left Ventricular Assist Device for the Treatment of Advanced Heart Failure in Patients Awaiting Heart Transplantation (2013) (0)
Advanced Heart Failure Patients Supported with Ambulatory Inotropic Therapy: What Defines Success of Therapy? (2021) (0)
Hemodynamic Support with Intra Aortic Balloon Pump Differs by Etiology of Cardiogenic Shock (2019) (0)
656 Similar Survival in Patients Following Heart Transplantion Receiving Induction Therapy Using Daclizumab Versus Basiliximab (2012) (0)
Successful Use of Temporary Percutaneous Right Ventricular Assist Devices in Acute Right Ventricular Failure After Acute Myocardial Infarction or LVAD Implantation (2017) (0)
Early Infection Risk Associated with Induction Immunosuppression after Cardiac Transplant in Patients with Left Ventricular Assist Devices (2019) (0)
Initial Post Approval Performance of the Heartware LVAD as Bridge to Transplantation: An Analysis of the UNOS Database (2014) (0)
Post-Discharge Quality of Life in Patients Receiving a Long-Term Ventricular Assist Device: Focus on Anxiety, Depression and Post Traumatic Stress Disorder. (2020) (0)
Malnutrition is Associated with Gut Dysbiosis and Perioperative Infections in LVAD Patients (2021) (0)
Fulminant Myocarditis in Fontan Patient Treated with Mechanical Circulatory Support and Heartmate 3 (2021) (0)
Right ventricular failure after thoracotomy left ventricular assist device; the role of pericardial restraint (2022) (0)
461 Recovery of Lipid Metabolism after Left Ventricular Assist Device Placement Predicts Short- and Long-Term Survival in End-Stage Heart Failure Patients (2011) (0)
RESIDUAL TRICUSPID REGURGITATION FOLLOWING TRICUSPID VALVE REPAIR DURING CONCOMITANT VALVE SURGERY DOES NOT WORSEN OVERALL SURVIVAL (2014) (0)
(249) - Prolonged Support Is Associated with Increased Risk of Cellular Rejection in Patient's Bridged to Transplantation with Continuous Flow Left Ventricular Assist Devices (2017) (0)
INCREASED INCIDENCE OF AORTIC INSUFFICIENCY IN HEARTMATE II COMPARED TO HEARTMATE I LEFT VENTRICULAR ASSIST DEVICE RECIPIENTS (2010) (0)
Heartmate 3 Implantation in Cancer Survivors with Advanced Heart Failure. (2020) (0)
The right wiring configuration for sternal closure: Science or mythology? (2017) (0)
Abstract 21394: Socioeconomic and Racial Disparities in Outcomes Among Patients Listed for Heart Transplant in the United States (2017) (0)
End-Stage Heart Failure-Which Surgical Options in the Era of Evidence Based Medicine? (2002) (0)
AORTIC ROOT THROMBOSIS IS ASSOCIATED WITH INCREASED INCIDENCE OF AORTIC INSUFFICIENCY IN PATIENTS SUPPORTED WITH HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICE (2021) (0)
Heart Failure Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure (2012) (0)
732 Preoperative Hypoalbuminemia Predicts Poor Prognosis in Patients Undergoing Left Ventricular Assist Device Implantation (2012) (0)
(1001) - Reliability of a Cuff-Deflation System for Serial Monitoring of Aortic Pulse Wave Velocity in Patients with Continuous-Flow Left Ventricular Assist Devices (2017) (0)
Primary Graft Dysfunction After Cardiac Transplantation Following Continuous-Flow Left Ventricular Device Support (2015) (0)
Abstract 16029: Early ECMO Overcomes Primary Graft Dysfunction After Heart Transplant (2017) (0)
Abstract 13291: Left Ventricular Assist Device Support is Associated with Sustained Cardiac CamKII Activation and Increased MEF2 (2014) (0)
489 Metabolic Syndrome Is Significantly Associated with Cardiac Allograft Vasculopathy: The Influence of Modifiable Risk Factors on Mortality in Patients Undergoing Orthotopic Heart Transplantation (2012) (0)
CARDIAC FUNCTION AND HEART FAILURE SHORT-TERM WAITING LIST SURVIVAL WITHOUT SUPPORT BY A VENTRICULAR ASSIST DEVICE (2010) (0)
Natural Antibodies and Left Ventricular Assist Device Complications (2019) (0)
Single-center experience with a minimally invasive apicoaxillary external ventricular assist device. (2014) (0)
149: Incidence of De Novo Solid Malignancies after Heart Transplantation Is Comparable to the General Population (2008) (0)
72 Multicenter clinical evaluation of the HeartMate II axial flow left ventricular assist device in patients with severe heart failure: hemodynamic effects, pump performance and quality of life (2006) (0)
281: Ventricular Assist Devices as Successful Bridge to Cardiac Re-Transplantation in Late Graft Failure: The Columbia-Presbyterian Experience (2009) (0)
Abstract 14021: Increased Cardiac Conduction Abnormalities After Tricuspid Annuloplasty During Cardiac Transplantation: A Single Center 3 Year Retrospective Review (2016) (0)
Abstract 17320: Does the Duration of Continuous Flow Left Ventricular Assist Device Support Influence Survival Following Heart Transplantation? (2014) (0)
Sternal healing comes from stable beginnings. (2017) (0)
247 Peak Exercise Capacity in Continuous-Flow Left Ventricular Assist Device Recipients May Be Determined by Right Ventricular Performance (2012) (0)
The Impact of Intrapericardial versus Intrapleural HeartMate 3 Pump Placement on Clinical Outcomes (2022) (0)
AORTIC ROOT THROMBOSIS IN PATIENTS WITH HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICES (2021) (0)
OP-EUJC200226 1..9 (2020) (0)
792 Feasibility and Flexibility of Magnetically Levitated Centrifugal-Flow Pump for Patients with Cardiogenic Shock (2012) (0)
Tacrolimus Time in Therapeutic Range is Associated with Cellular Rejection and Gut Dysbiosis Early after Heart Transplant (2021) (0)
Discriminatory Performance of Simple Urine Dipstick for Detection of Significant Hemolysis in CF-LVAD Patients (2015) (0)
Stroke Subtype Impacts Outcomes and Transplant Eligibility in CF-LVADS (2015) (0)
Low Levels of Inflammation and Congestion at the First Outpatient Visit after LVAD Implant Predict Lower Risk for Readmission and More Days-Alive-out-of-Hospital (2021) (0)
Minimally invasive and robotic treatment of atrial fibrillation using microwave energy (2003) (0)
Concurrent Mitral Valve Repair during Placement of Continuous-Flow Left Ventricular Assist Device (2019) (0)
Abstract 3645: RAGE Impairs Angiogenesis Consequent to Femoral Artery Ligation in Diabetic Mice (2008) (0)
Short-, Mid- and Long-Term Efficacy of Aortic Valve Repair in Patients Supported with Continuous Flow-Left Ventricular Assist Device (2016) (0)
Sex Related Differences in Patients with Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation. (2020) (0)
Prospective Evaluation of Urine Dipstick for Detection of Significant Hemolysis in Outpatients on CF-LVAD Support (2016) (0)
Relationship Between Oral Microbiota, Inflammation and Congestion Among Advanced Heart Failure Patients (2018) (0)
Potentiation of endogenous fibrinolysis and rescue from lung ischemia-reperfusion injury by IL-10 (1999) (0)
(1002) - Predictors of Ventricular Recovery After Acute Myocardial Infarction Complicated by Cardiogenic Shock (2017) (0)
489 Studies on the regulatory mechanism of human endometrial decidualization. (1989) (0)
Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib (2022) (0)
HM3 Patients Do Not Have an Increased Pulsatility in Large, Muscular or Microcirculatory Arteries. (2020) (0)
617: Leukocyte Gene Expression Profiles of Hyperbilirubinemia Following Mechanical Circulatory Support Device Implantation (2009) (0)
Effect of Device Thrombosis and Malfunction on Clinical Outcomes of Patients Bridging With Continuous-Flow LVADs (2015) (0)
Blood Flow Kinetic Energy of Right Ventricular Outflow Tract: A Marker for Right Ventricular Global Systolic Function (2019) (0)
PROGNOSTIC IMPLICATIONS OF TRICUSPID REGURGITATION IN PATIENTS UNDERGOING AORTIC VALVE REPLACEMENT (2014) (0)
676 New Onset Atrial Fibrillation and Atrial Flutter after Cardiac Transplant Is Associated with High Mortality and Cardiac Allograft Vasculopathy (2012) (0)
The Utility of Televisits in Patients with a Left Ventricular Assist Device (2021) (0)
THE RELATIONSHIPS BETWEEN RENAL RESISTIVE INDEX AND CORONARY RISK FACTORS AND CORONARY HEART DISEASE (2018) (0)
Increased Levels of Osteopontin Are Associated with Development of Right Ventricular Failure after Ventricular Assist Device Implantation in Patients with Advanced Heart Failure (2011) (0)
Abstract 20420: Pulmonary Vascular Resistance (PVR) Does Not Affect One-Year Mortality After Heart Transplantation (HTx) Both in LVAD and Non-LVAD Cohorts: Should There Be Any Cut-Off Value in the Current Era? (2017) (0)
Endoscopic Evaluation in Patients with CF-LVADs with Gastrointestinal Bleeding: Are We Ready for a Paradigm Shift to Improve Care? (2017) (0)
(667) - Medical Management of Device Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients: Success Rate and Outcomes (2017) (0)
333: Center experience and outcomes of left-ventricular assist device (LVAD) implantation as destination therapy (DT) – analysis of thoratec DT registry 1998-2005 (2007) (0)
Contemporary Outcomes of Heart Transplantation in Adult Patients with Congenital Heart Disease and Prior Intracardiac Repair: Analysis from UNOS Database. (2020) (0)
Middle cerebral artery pulsatility in heart failure and patients with continuous-flow left ventricular assist devices (2017) (0)
Abstract 16561: Mechanical Unloading via Left Ventricular Assist Device Implantation Ameliorates Systemic and Adipose Tissue Inflammation and Increases Adipocyte Size in Patients With Advanced Heart Failure (2011) (0)
Incidence and Outcome of Neurological Complications in Veno-Arterial Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock (2019) (0)
CARDIAC ALLOGRAFT HYPERTROPHY: AN IMPORTANT PROGNOSTIC MARKER FOR CARDIAC ALLOGRAFT VASCULOPATHY (2012) (0)
533 Analysis of Long-Term Outcome of Patients with Cardiac Sarcoidosis Undergoing Heart Transplantation (2011) (0)
Abstract 18828: Comprehensive Lipidomic Analysis of Myocardial and Circulating Acylcarnitine Levels in Patients With Advanced Heart Failure Before and After Mechanical Unloading and Controls (2013) (0)
283: Post Transplant Survival Following Support with a Continuous Flow Left Ventricular Assist Device (2009) (0)
Implantable Ventricular Assist Device Use in the Immunosuppressed Patient (2013) (0)
INCREASED INSULIN SENSITIVITY IN ADVANCED HEART FAILURE PATIENTS TREATED WITH LEFT VENTRICULAR ASSIST DEVICE (2010) (0)
Cardiothoracic surgery on patients with mechanical circulatory support devices (2012) (0)
EL PATIENT SELECTION FOR LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION : AN ENDLESSLY MOVING TARGET (2007) (0)
Estimation of Mean Arterial Pressure Using Doppler and Pump Parameters in HeartMate 3 Patients. (2020) (0)
IMPACT OF PREOPERATIVE LYMPHOPENIA ON OUTCOMES AFTER HEART TRANSPLANT (2021) (0)
Preoperative screening scale predicts prolonged icu stay after implantation of left ventricular assist devices (2004) (0)
Long-term Outcome of Patients Bridged to Recovery After Short-term Mechanical Circulatory Support for Cardiogenic Shock (2018) (0)
Abstract 13707: Increased Bone Turnover and Resorption in Patients with Advanced Heart Failure is Corrected by Hemodynamic Improvement Through Ventricular Assist Device Implantation (2011) (0)
Abstract P311: CAPTURE: Cardio-Pulmonary Tissue Repository (2011) (0)
Deep vein thrombosis and pulmonary embolism after heart transplantation (2022) (0)
(354) - Vasoactive-Inotropic Score Is Associated with In-Hospital Mortality in Continuous Flow Left Ventricular Assist Device Patients (2017) (0)
OUTCOMES AFTER HEART TRANSPLANTATION FOR LIGHT-CHAIN COMPARED TO TRANSTHYRETIN AMYLOIDOSIS (2019) (0)
339: Whole Transcriptome Analysis of Changes in Immune Function Early after Mechanical Circulatory Support Device Implantation in End Stage Heart Failure Patients (2009) (0)
Preoperative Prediction of Severe Intestinal Ischemia in Strangulation Ileus. (1992) (0)
Abstract 18709: Myostatin Expression is Markedly Increased after Biventricular Mechanical Support in Congenital Heart Disease (2010) (0)
VKORC1 Genotype Predicts Warfarin Dosing and INR Kinetics in Patients With Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2015) (0)
The Impact of Aortic Valve Opening Status on Bleeding and Thrombotic Risk in Patients with CF-LVAD (2014) (0)
Pre-Operative Intracardiac Thrombus is Associated with Increased Risk of Stroke and Death in CF-LVAD Patients. (2020) (0)
39: Use of a Murine Transcutaneous Ventricular Assist Device Driveline Model To Characterize S. epidermidis SDRF Binding (2008) (0)
Abstract 14275: Improvement of Skeletal Muscle Function and Oxidative Capacity, Systemic Inflammation and Growth Hormone/Insulin-Like Growth Factor-1 Signaling in Patients With Advanced Heart Failure Following Ventricular Assist Device Implantation (2011) (0)
Does the time between ventricular assist device implantation and heart transplantation affect survival? (2004) (0)
Abstract 15702: Neutrophil Gelatinase-associated Lipocalin (NGAL) Correlates With Impaired Renal Function In Patients With Advanced Heart Failure And Corrects After Ventricular Assist Device Placement (2011) (0)
57. The Concentrations of Pregnancy Specific β_1-glycoprotein (SP_1) in Saliva and Gastric Juice of Pregnant Women (1986) (0)
Elevated Serum C-reactive Protein (CRP) Level Predicts Increased Post-Implant Mortality in Patients Undergoing HeartMate 3 LVAD Implantation. (2020) (0)
EFFICACY OF SURGICAL AND MEDICAL INTERVENTION FOR TREATMENT OF LEFT-SIDED INFECTIVE ENDOCARDITIS (2019) (0)
Global Myocardial Viability by Thallium-201 Redistribution Imaging Can Predict Successful Weaning from Short Term Mechanical Support (2014) (0)
Pulmonary Artery Decoupling Further Enhances Discriminatory Power of Pulmonary Vascular Resistance in Patients Bridged to Transplant with Left Ventricular Assist Devices (2018) (0)
Continuous Flow Left Ventricular Assist Device as a Risk Factor for Intraoperative Vasoplegia during Orthotopic Heart Transplantation (2016) (0)
663 Cardiac Allograft Hypertrophy: An Important Prognostic Marker for Cardiac Allograft Vasculopathy (2012) (0)
Reduced Serum Albumin Concentration before Heart Transplantation Predicts Poor Post-Transplant Prognosis (2011) (0)
149: Transcription repression factor Nab1 downregulation in the failing heart after BiVAD support (2006) (0)
Hemodynamic Determinants of Decline in Renal Function During Left Ventricular Assist Device Support (2018) (0)
Abstract 15874: The Effect of Socioeconomic Status on Patients Supported With Contemporary Left Ventricular Assist Devices (2017) (0)
IMPACT OF UNCORRECTED CONCOMITANT MODERATE FUNCTIONAL MITRAL REGURGITATION ON SURVIVAL IN PATIENTS UNDERGOING AORTIC VALVE REPLACEMENT (2014) (0)
Feasibility of Long Term Use of External Continuous Flow Ventricular Assist Device (2015) (0)
Abstract 19271: Lack of Sufficient Pulsatile Flow in the Microvasculature May Contribute to Increased Microvascular Complications in Patients Implanted With Continuous Flow Left Ventricular Assist Devices (2015) (0)
Long- and Short-Term Changes in Serum Creatinine Prior to LVAD Surgery are Associated with Postoperative Outcomes (2019) (0)
Novel Palliative Care Integration Program increases Days Alive and Out of Hospital and Reduces Inpatient Direct Costs Among Left Ventricular Assist Device Patients (2017) (0)
357: Acquired Von Willebrand Disease Frequently Occurs in Continuous Flow Left Ventricular Assist Devices (2010) (0)
400 Role of α-atrial natriuretic peptide (α ANP) in human fetal membranes. (1990) (0)
9: Use of Mechanical Support Devices in Patients with Mechanical Mitral Valve Prosthesis (2010) (0)
Home INR Monitoring: Does It Help Reduce the Chance of Re-Admission for LVAD Patients? (2013) (0)
A Prospective Comparison of Veno-Arterial Extra-Corporeal Membrane Oxygenation and a Percutaneous Ventricular Assist Device for Cardiogenic Shock Following Acute Myocardial Infarction (2018) (0)
Characteristics and Short-Term Outcomes of Hepatitis C Antibody Positive Organs for Heart Transplantation: UNOS Analysis (2019) (0)
Atrial Fibrillation in Patients Supported by Continuous-Flow Left Ventricular Assist Device (2014) (0)
Differences In 24-Hour Vascular Hemodynamic Profiles Among Healthy Subjects, Heart Failure, Left Ventricular Assist Device and Heart Transplant Patients (2018) (0)
422: Clinical Outcome of Orthotopic Heart Transplantation for End-Stage Heart Disease Due to Mediastinal Radiation Therapy (2009) (0)
Abstract 10318: Liver Dysfunction and Dynamics in Liver Function Parameters Predict Survival of Patients with Advanced Heart Failure Requiring Ventricular Assist Device Placement (2011) (0)
P103 Improved Metabolic Vasoreactivity in the Brain of HM3 Patients and its Underlying Microcirculatory Mechanisms (2020) (0)
Effects of Hospital Characteristics on In-Hospital Mortality and Hospitalization Costs for Mechanical Circulatory Support Device (MCSD) Therapy: Results from the National (Nationwide) Inpatient Sample (NIS) (2017) (0)
Outcomes Associated With Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-analysis (2018) (0)
Clonal Composition and Specificity of Graft Infiltrating B Cells in Human Cardiac Allograft Vasculopathy (2015) (0)
Relationship of Factor II and Factor X Activity with International Normalized Ratio (INR) in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients: A Cross-Sectional Study (2016) (0)
EARLY AND LATE MORTALITY IN PATIENTS WITH LOW BODY WEIGHT UNDERGOING AORTIC VALVE REPLACEMENT (2014) (0)
Outcomes of Mechanical Circulatory Support Therapy for Cardiogenic Shock Associated with Late Allograft Failure after Heart Transplantation. (2020) (0)
280: Higher Center Volume with Bridge-to-Transplant Recipients Predicts Superior Post-Transplant Outcomes in Bridged and Non-Bridged Recipients (2009) (0)
Predictors of Neurologic Outcomes After Extracorporeal Cardiopulmonary Resuscitation (2018) (0)
8: Development of Aortic Insufficiency in Patients Supported with a HeartMate II Left Ventricular Assist Device (LVAD) (2010) (0)
412: Gender related considerations in patients referred for heart transplant evaluation (2007) (0)
Abstract 13812: Preoperative Risk Assessment of High Risk Heart Transplantation Candidates to Predict Survival Following Heart Transplantation (2011) (0)
486: Cognitive Impairment in Heart Failure: It Is More Than Just Depression (2008) (0)
Predictors of Survival to Discharge After VA-ECMO Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock (2018) (0)
Abstract 19882: Ventricular Assist Device Implantation Corrects Impairment of Growth Hormone/Insulin-like Growth Factor-1 Signaling in Patients with Advanced Heart Failure (2010) (0)
Abstract 21350: Outcomes With Steroid-Free Maintenance Immunosuppression After Heart Transplant: Results From the United Network for Organ Sharing Registry (2017) (0)
Left Ventricular Assist Device Troubleshooting: Hypotension (2020) (0)
Reliability of a Novel Slow Cuff-Deflation System for Non-Invasive Blood Pressure Monitor in Out-Patients with Continuous-Flow Left Ventricular Assist Devices (2011) (0)
381 Whoa Baby! Successful Vaginal Delivery in a Woman with a Dilated Cardiomyopathy Supported with a Left Ventricular Assist Device (2011) (0)
Abstract 18842: Point of Care Testing Overestimates INR in CF-LVAD Patients (2014) (0)
INCREASE IN LEAKAGE OF MYOCARDIAL ENZYMES BY THE STRESS OF CARDIAC BEATING AFTER INCREASE IN CELL MEMBRANE FRAGILITY BY ANOXIA : Pathophysiology : 53 Annual Scientific Meeting, Japanese Circulation Society (1989) (0)
Safety of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation (2014) (0)
(1018) - Predictors of Mortality in Cardiogenic Shock Patients Treated with Extra-Corporeal Cardiopulmonary Resuscitation (2017) (0)
Comparison of Survival and Modes of Death by ICD Status Among LVAD Recipients (2017) (0)
CHAPTER 47 – Ventricular Assist Device Therapy in Advanced Heart Failure—State of the Art (2010) (0)
Original article: cardiovascularinvited commentary (2002) (0)
Normalization of Pulmonary Hypertension by the Use of Left Ventricular Assist Device in Patients with End-stage Heart Failure: A Possible Contribution to Donor Pool Expansion in Lung Transplantation☆ (2014) (0)
(521) - Is the ISHLT-Suggested Inotrope Score a Predictor of In-Hospital Mortality After Heart Transplantation? (2017) (0)
Abstract 16915: Preoperative Risk Assessment of Patients with Advanced Heart Failure Evaluated for Cardiac Transplantation to Predict Survival Following Heart Transplantation (2011) (0)
Extracoporeal Membrane Oxygenator or Ventricular Assist Device for Primary Graft Failure after Orthotopic Heart Transplantation (2016) (0)
Combined Renal Risk Score Predicts Post-Implant Renal Failure in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients (2016) (0)
109 End-of-Life Care in Recipients of Magnetically Levitated Centrifugal-Flow Pump (2012) (0)
Outcomes of Continuous-Flow Left Ventricular Assist Device Insertion for Acute Myocardial Infarction and Cardiogenic Shock: Importance of Bridging Strategy (2016) (0)
Predictors of Postoperative Vasoplegia in Patients Receiving Left Ventricular Assist Devices (2018) (0)
Novel Percutaneous Dual Lumen Cannula Right Ventricular Assist Device Provides Effective Support for Patients after Left Ventricular Assist Device Implantation (2019) (0)
Six-Month Outcomes of Heart Transplant Recipients Infected by COVID-19 (2021) (0)
Use of ventricular assist device technology as part of therapy continuum to promote recovery for acute myocardial infarction with cardiogenic shock: a U.S. multicenter study (2006) (0)
Use of Phosphodiesterase 5 Inhibitors in Continuous-Flow Left Ventricular Assist Device Patients With Pulmonary: Hypertension: A Contemporary Analysis (2015) (0)
Gender Bias in LVAD Referral Patterns - A Survey of Patients and Providers (2019) (0)
Palliative Care Effectively Guides Transition to Inpatient Hospice, Home Hospice or Home Services for End-of-Life Care of LVAD Patients (2015) (0)
Abstract 4047: High Volume Transplant Centers Achieve Better Post-transplant Survival In Low And High-risk Recipients (2009) (0)
The hub-and-spoke sysytem in treating acute cardiogenic shock: who survives? (2003) (0)
Changes in Lipid Profile Subfractions on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Therapy (2016) (0)
Gut Microbiome-Generated Metabolite Trimethylamine-N-Oxide is Reduced After Heart Transplantation and Continuous Flow Left Ventricular Assist Device Therapy in Advanced Heart Failure Patients (2018) (0)
Ideal Body Weight May Be A Better Comparative Variable than Actual Body Weight for Donor-Recipient Matching in Orthotopic Heart Transplantation (2018) (0)
406: Estimated GFR predicts survival following heart transplantation (2007) (0)
466 Ventricular Assist Device Implantation Corrects Systemic and Peripheral Impairment of Growth Hormone/Insulin-Like Growth Factor-1 Signaling in Patients with Advanced Heart Failure (2011) (0)
Abnormal Thyroid Function in Patients With Advanced Heart Failure Reverses after Heart Transplantation (2010) (0)
Difficulty in Dying on LVAD: A Preliminary Analysis of Factors Associated with Time to LVAD Withdrawal (2019) (0)
Contemporary Outcomes of Mechanical Circulatory Support for Cardiogenic Shock: Single Center Experience of over 300 Patients (2016) (0)
746 Speed Adjustment and Thrombosis Detection in Continuous Flow Pumps: Utility of Ramp Studies (2012) (0)
Preemptive Hemodynamic Transesophageal Echocardiography after Continuous Flow Ventricular Assist Device Implantation (2019) (0)
786 Isolated Right Ventricular Assist Device Support Does Not Predict Better Survival over Biventricular Support for Primary Graft Failure after Orthotopic Heart Transplant (2012) (0)
(1066) - Effect of Arterial Cannulation Site on Cerebral Blood Flow During Peripheral Venoarterial Extracorporeal Membrane Oxygenation (2017) (0)
Comparison of Outcomes Following Heart Replacement Therapy in Patients Over 65 Years Old (2015) (0)
45: The association between body mass index and long term survival in patients undergoing heart transplantation (2006) (0)
Left Ventricular Assist Device Therapy Increases the Incidence of Monomorphic Ventricular Tachycardia (2004) (0)
Initial FDA Post-Approval Study INTERMACS Registry Results with a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation (2009) (0)
Impact of Socioeconomic Status on Bridging with Contemporary Left Ventricular Assist Device (LVAD): Analysis of the UNOS Registry (2016) (0)
Abstract 20164: Profiling of Circulating MicroRNAs After Heart Transplantation and During Acute Cellular and Antibody-Mediated Rejection (2014) (0)
Ventricular Assist Device Implantation Corrects Skeletal Muscle Function, Oxidative Capacity and Local Expression of Insulin-Like Growth Factor-1 in Patients with Advanced Heart Failure (2011) (0)
The Impact of Acute Kidney Injury in Patients With Postcardiotomy Cardiogenic Shock Requiring Mechanical Circulatory Support (2015) (0)
Long-Term Outcomes of Orthotopic Heart Transplantation in Patients with Cardiac Amyloidosis: Differential Survival by Amyloid Type (2013) (0)
Cystatin C- vs. Creatinine- Based Assessment of Renal Function in Patients Admitted with Heart Failure: Insights from DOSE, ROSE and CARRESS-HF (2021) (0)
C-reactive Protein Levels Predict Right Ventricular Failure and Mortality in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Assist Device Implantation: An INTERMACS Analysis. (2020) (0)
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation (2022) (0)
Aortic Regurgitation in Patients with Left Ventricular Assist Devices (2019) (0)
The Association of Renal Dysfunction with Gut Dysbiosis in Heart Failure, LVAD and Heart Transplant Patients - A Mediation Analysis (2021) (0)
Impact of Preoperative Atrial Fibrillation on Patients with the HeartMate 3. (2020) (0)
P90 KINETIC ENERGY AND ENERGY LOSS IN THE MIDDLE CEREBRAL ARTERY (MCA) OF HEARTMATE II PATIENTS (2018) (0)
Feasibility Trial Results of the VentrAssist 3rd Generation LVAD for Bridge to Cardiac Transplantion (2007) (0)
Abstract 20054: Myocardial Expression and Circulating Serum Levels of the Extracellular Matrix Markers MMP-2, MMP-9 and Osteopontin in Patients with Advanced Heart Failure Undergoing Ventricular Assist Device Placement (2010) (0)
The Impact of Concomitant Mitral Repair in Patients Receiving Continuous-Flow Left Ventricular Assist Devices (2015) (0)
Variability in Gene Expression Profiling (GEP) Identifies Heart Transplant Recipients at Risk for Acute Cellular Rejection but Not Cardiac Allograft Vasculopathy (2017) (0)
(129) - Mechanical Circulatory Support for Patients in Cardiogenic Shock After Right Ventricular Infarction: A Single-Center Experience (2017) (0)
Perioperative Management of Patients Receiving Short-term Mechanical Circulatory Support with the Transvalvular Heart Pump. (2022) (0)
Less is better? Comparing effects of median sternotomy and thoracotomy surgical approaches for left ventricular assist device implantation on postoperative outcomes and valvulopathy. (2022) (0)
Abstract 17120: Association of Endotoxemia and Endothelin-1 With Development of Cardiac Allograft Vasculopathy After Heart Transplantation (2020) (0)
Acute Occlusion of the Left Anterior Descendent Artery Activates the IL6 Pathway and Important IL6-Dependent Pathways Which Are Abrogated in the IL6-/- Mouse (2006) (0)
Long Term Left Ventricular Assist Device as Bridge to Heart Transplantation: De Facto Destination Therapy in Many? (2010) (0)
Abstract 15758: Peak Oxygen Consumption Does Not Depend on Aortic Valve Opening During Exercise in Patients with a Continuous Flow Left Ventricular Assist Device (2011) (0)
Inflammation Mediated Fibrosis Is Regulated Through Distinct Gene-Gene Co-Expression Networks in the Failing Human Myocardium Before and After Left Ventricular Assist Device Support (2015) (0)
449 The Outcome of Patients with Idiopathic Non-Dilated Hypertrophic Cardiomyopathy Following Cardiac Transplantation (2012) (0)
Causes and Temporal Patterns of Hospital Readmissions after Implantation of the HeartMate 3 Left Ventricular Assist Device: A Comparison with HeartMate II (2021) (0)
Heart transplantation and long-term mechanical support in Japan: progress at last. (2011) (0)
793 Addition of Mitral Valve Repair to Left Ventricular Assist Device Implantation (2012) (0)
Abstract 3378: Post-transplant Survival is Not Diminished in Heart Transplant Recipients Bridged With Implantable Left Ventricular Assist Devices (2009) (0)
35 Predictors of Right Ventricular Assist Device Following Left Ventricular Assist Device Implantation: An Assessment of Scoring Systems (2011) (0)
101: Are bridge to recovery patients sick enough to require ventricular assist device in refractory acute myocardial infarction cardiogenic shock?: Benchmark against the SHOCK trial (2007) (0)
297: Sensitization in axial flow devices versus pulsatile left ventricular assist devices (2006) (0)
(142) - A Genotype Guided Warfarin Protocol Improves Anticoagulation Quality Early After LVAD Implantation (2017) (0)
Hepatic Function After Long-Term Continuous-Flow Left Ventricular Assist Device Support (2015) (0)
Serum Cystatin C as a Predictor of Early Outcomes and Long-Term Mortality in Contemporary LVAD Patients. (2020) (0)
Post-Discharge Quality of Life with a Long-Term Ventricular Assist Device: Focus on Functional Disability and Impact of Health Status. (2020) (0)
Predictors of Survival to Discharge and Ventricular Recovery after VA-ECMO Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock (2019) (0)
Comparison of Predictors and Outcomes of Severe LV and RV Primary Graft Dysfunction in Heart Transplant Recipients (2018) (0)
Use of Durable Continuous-Flow Ventricular Assist Devices in Patients on Immunosuppression (2017) (0)
Commentary: The role of mechanical circulatory support in heart retransplantation. (2020) (0)
Safety and Efficacy of Pre Transplant Desensitization of Patients Supported by CF-LVADs (2014) (0)
Electrical Remodeling After Continuous-Flow Left Ventricular Assist Device Implantation (2016) (0)
A CASE OF DUODENAL CARCINOID (1991) (0)
Paper # 84: ACL Reconstruction Using Bone-Tendon-Bone Graft Engineered from the Semitendinosus Tendon by Injection of Recombinant BMP-2 in a Rabbit Model (2011) (0)
Comprehensive Nutrition Assessment before Left Ventricular Assist Device Implantation in Chronically Ill Hospitalized Patients (2019) (0)
How can we better inform our patients about post‐heart transplantation survival? A conditional survival analysis (2021) (0)
Abstract 18617: Development of Aortic Root Dilation is Accompanied by Increased Vascular Expression of Proinflammatory Adhesion Molecules VCAM, ICAM and E-Selectin in Patients with Advanced Heart Failure Following Left Ventricular Assist Device Placement (2012) (0)
(264) - Bridging to Transplantation with Contemporary Continuous-Flow Left Ventricular Assist Devices: A Decade Experience (2017) (0)
421 Elevations in Donor Troponin Levels Do Not Predict Worse Outcomes Following Orthotopic Heart Transplant (2012) (0)
Anti tumor necrotic factor agents promote the ability of the BMP-2 induced ectopic bone formation (2009) (0)
The Effect of Anticoagulation on Bleeding and Thrombotic Events during Extracorporeal Membrane Oxygenation Support for Postcardiotomy Shock. (2020) (0)
Abstract 17084: Left Ventricular Assist Device Restores Circadian Hemodynamic Variability in Advanced Heart Failure Patients (2017) (0)
Predictive Value of Mean Arterial Pressure Versus Systolic Blood Pressure and Visit-To-Visit Blood Pressure Variability for Stroke and Pump Thrombosis in HeartMate II Patients (2018) (0)
Cardiac Recovery in Patients with Adriamycin-Induced Cardiomyopathy After Left Ventricular Assist Device Support (2018) (0)
313: Outcomes of Medical Therapy and Mechanical Circulatory Support as Bridge to Transplantation in UNOS Status 1 Heart Transplant Candidates – Analysis of the U.S. UNOS/OPTN Data, Years 1999-2007 (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Yoshifumi Naka?

Yoshifumi Naka is affiliated with the following schools:

University of Florida
Columbia University
Duke University

Yoshifumi Naka's Academic­Influence.com Rankings

Yoshifumi Naka's Degrees

Why Is Yoshifumi Naka Influential?

Yoshifumi Naka's Published Works

Published Works

What Schools Are Affiliated With Yoshifumi Naka?

Yoshifumi Naka's AcademicInfluence.com Rankings